<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Hum Genet</journal-id><journal-title-group><journal-title>Human Genetics</journal-title></journal-title-group><issn pub-type="ppub">0340-6717</issn><issn pub-type="epub">1432-1203</issn><publisher><publisher-name>Springer-Verlag</publisher-name><publisher-loc>Berlin/Heidelberg</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">21061022</article-id><article-id pub-id-type="pmc">3020305</article-id><article-id pub-id-type="publisher-id">910</article-id><article-id pub-id-type="doi">10.1007/s00439-010-0910-8</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Investigation</subject></subj-group></article-categories><title-group><article-title><italic>AKT1</italic> polymorphisms are associated with risk for metabolic syndrome</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Devaney</surname><given-names>Joseph M.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Gordish-Dressman</surname><given-names>Heather</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Harmon</surname><given-names>Brennan T.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Bradbury</surname><given-names>Margaret K.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Devaney</surname><given-names>Stephanie A.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Harris</surname><given-names>Tamara B.</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Thompson</surname><given-names>Paul D.</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Clarkson</surname><given-names>Priscilla M.</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Price</surname><given-names>Thomas B.</given-names></name><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Angelopoulos</surname><given-names>Theodore J.</given-names></name><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><name><surname>Gordon</surname><given-names>Paul M.</given-names></name><xref ref-type="aff" rid="Aff7">7</xref></contrib><contrib contrib-type="author"><name><surname>Moyna</surname><given-names>Niall M.</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name><surname>Pescatello</surname><given-names>Linda S.</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name><surname>Visich</surname><given-names>Paul S.</given-names></name><xref ref-type="aff" rid="Aff10">10</xref></contrib><contrib contrib-type="author"><name><surname>Zoeller</surname><given-names>Robert F.</given-names></name><xref ref-type="aff" rid="Aff11">11</xref></contrib><contrib contrib-type="author"><name><surname>Seip</surname><given-names>Richard L.</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Seo</surname><given-names>Jinwook</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Kim</surname><given-names>Bo Hyoung</given-names></name><xref ref-type="aff" rid="Aff12">12</xref></contrib><contrib contrib-type="author"><name><surname>Tosi</surname><given-names>Laura L.</given-names></name><xref ref-type="aff" rid="Aff13">13</xref></contrib><contrib contrib-type="author"><name><surname>Garcia</surname><given-names>Melissa</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Rongling</given-names></name><xref ref-type="aff" rid="Aff14">14</xref></contrib><contrib contrib-type="author"><name><surname>Zmuda</surname><given-names>Joseph M.</given-names></name><xref ref-type="aff" rid="Aff15">15</xref></contrib><contrib contrib-type="author"><name><surname>Delmonico</surname><given-names>Matthew J.</given-names></name><xref ref-type="aff" rid="Aff16">16</xref></contrib><contrib contrib-type="author"><name><surname>Lindsay</surname><given-names>Robert S.</given-names></name><xref ref-type="aff" rid="Aff17">17</xref></contrib><contrib contrib-type="author"><name><surname>Howard</surname><given-names>Barbara V.</given-names></name><xref ref-type="aff" rid="Aff18">18</xref></contrib><contrib contrib-type="author"><name><surname>Kraus</surname><given-names>William E.</given-names></name><xref ref-type="aff" rid="Aff19">19</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Hoffman</surname><given-names>Eric P.</given-names></name><address><phone>+1-202-8846011</phone><fax>+1-202-8846014</fax><email>ehoffman@cnmcresearch.org</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label>Department of Integrative Systems Biology, Research Center for Genetic Medicine, Children&#x02019;s National Medical Center, 111 Michigan Ave. NW, Washington, DC, 20010 USA </aff><aff id="Aff2"><label>2</label>National Institute of Aging, National Institutes of Health, Bethesda, MD 20892 USA </aff><aff id="Aff3"><label>3</label>Division of Cardiology, Henry Low Heart Center, Hartford Hospital, Hartford, CT 06102 USA </aff><aff id="Aff4"><label>4</label>Department of Kinesiology, University of Massachusetts, Amherst, MA 01003 USA </aff><aff id="Aff5"><label>5</label>Department of Diagnostic Radiology, Yale University School of Medicine, New Haven, CT 06520 USA </aff><aff id="Aff6"><label>6</label>Department of Health Professions, Center for Lifestyle Medicine, University of Central Florida, Orlando, FL 32816 USA </aff><aff id="Aff7"><label>7</label>Laboratory for Physical Activity and Exercise Intervention Research, University of Michigan, Ann Arbor, MI 48108 USA </aff><aff id="Aff8"><label>8</label>Department of Sport Science and Health, Dublin City University, Dublin 9, Ireland </aff><aff id="Aff9"><label>9</label>School of Allied Health, University of Connecticut, Storrs, CT 06269 USA </aff><aff id="Aff10"><label>10</label>Human Performance Laboratory, Central Michigan University, Mount Pleasant, MI 48859 USA </aff><aff id="Aff11"><label>11</label>Department of Exercise Science and Health Promotion, Florida Atlantic University, Davie, FL 33314 USA </aff><aff id="Aff12"><label>12</label>INFINITT Technology, Seoul, Korea </aff><aff id="Aff13"><label>13</label>Orthopedic Surgery and Sports Medicine, Children&#x02019;s National Medical Center, Washington, DC, 20010 USA </aff><aff id="Aff14"><label>14</label>Department of Preventive Medicine, University of Tennessee, Memphis, TN 39163 USA </aff><aff id="Aff15"><label>15</label>Department of Epidemiology and Human Genetics, University of Pittsburgh, Pittsburgh, PA 15261 USA </aff><aff id="Aff16"><label>16</label>Department of Kinesiology, University of Rhode Island, Kingston, RI 02881 USA </aff><aff id="Aff17"><label>17</label>Faculty of Medicine, University of Glasgow, Glasgow, UK </aff><aff id="Aff18"><label>18</label>MedStar Research Institute, Hyattsville, MD 20783 USA </aff><aff id="Aff19"><label>19</label>Duke Center for Living, Duke University Medical Center, Durham, NC 27710 USA </aff></contrib-group><pub-date pub-type="epub"><day>9</day><month>11</month><year>2010</year></pub-date><pub-date pub-type="pmc-release"><day>9</day><month>11</month><year>2010</year></pub-date><pub-date pub-type="ppub"><month>2</month><year>2011</year></pub-date><volume>129</volume><issue>2</issue><fpage>129</fpage><lpage>139</lpage><history><date date-type="received"><day>10</day><month>6</month><year>2010</year></date><date date-type="accepted"><day>17</day><month>10</month><year>2010</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2010</copyright-statement></permissions><abstract><p>Converging lines of evidence suggest that AKT1 is a major mediator of the responses to insulin, insulin-like growth factor 1 (IGF1), and glucose. AKT1 also plays a key role in the regulation of both muscle cell hypertrophy and atrophy. We hypothesized that <italic>AKT1</italic> variants may play a role in the endophenotypes that make up metabolic syndrome. We studied a 12-kb region including the first exon of the <italic>AKT1</italic> gene for association with metabolic syndrome-related phenotypes in four study populations [FAMUSS cohort (<italic>n</italic>&#x000a0;=&#x000a0;574; age 23.7&#x000a0;&#x000b1;&#x000a0;5.7&#x000a0;years), Strong Heart Study (SHS) (<italic>n</italic>&#x000a0;=&#x000a0;2,134; age 55.5&#x000a0;&#x000b1;&#x000a0;7.9&#x000a0;years), Dynamics of Health, Aging and Body Composition (Health ABC) (<italic>n</italic>&#x000a0;=&#x000a0;3,075; age 73.6&#x000a0;&#x000b1;&#x000a0;2.9&#x000a0;years), and Studies of a Targeted Risk Reduction Intervention through Defined Exercise (STRRIDE) (<italic>n</italic>&#x000a0;=&#x000a0;175; age 40&#x02013;65&#x000a0;years)]. We identified a three SNP haplotype that we call H1, which represents the ancestral alleles at the three loci and H2, which represents the derived alleles at the three loci. In young adult European Americans (FAMUSS), H1 was associated with higher fasting glucose levels in females. In middle age Native Americans (SHS), H1 carriers showed higher fasting insulin and HOMA in males, and higher BMI in females. In older African-American and European American subjects (Health ABC) H1 carriers showed a higher incidence of metabolic syndrome. Homozygotes for the H1 haplotype showed about twice the risk of metabolic syndrome in both males and females (<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.001). In middle-aged European Americans with insulin resistance (STRRIDE) studied by intravenous glucose tolerance test (IVGTT), H1 carriers showed increased insulin resistance due to the Sg component (<italic>p</italic>&#x000a0;=&#x000a0;0.021). The 12-kb haplotype is a risk factor for metabolic syndrome and insulin resistance that needs to be explored in further populations.</p><sec><title>Electronic supplementary material</title><p>The online version of this article (doi:10.1007/s00439-010-0910-8) contains supplementary material, which is available to authorized users.</p></sec></abstract><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer-Verlag 2011</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p>AKT1 [also called protein kinase B (PKB)] is involved in two major signaling pathways: the regulation of muscle hypertrophy and atrophy (Nader <xref ref-type="bibr" rid="CR19">2005</xref>) and AKT1 is mediator of the biological functions of insulin and augments glucose uptake in muscle, adipocytes and liver along with a host of other tissues (Elghazi et al. <xref ref-type="bibr" rid="CR8">2006</xref>; Zdychova and Komers <xref ref-type="bibr" rid="CR38">2005</xref>). AKT1 mediates glucose uptake by inducing translocation of vesicles containing GLUT4 from intracellular stores to the plasma membrane (Hajduch et al. <xref ref-type="bibr" rid="CR11">1998</xref>). Briefly, upon insulin stimulation, AKT1 agonists activate receptor kinase functions that result in the stimulation of tyrosine phosphorylation of substrates such as IRS1 (Sun et al. <xref ref-type="bibr" rid="CR30">1991</xref>) and IRS2 (Sun et al. <xref ref-type="bibr" rid="CR31">1995</xref>). Tyrosyl phosphorylation of the IRSs provides binding sites for specific proteins containing Src-homology 2 (SH<sub>2</sub>) domains such as PI3K. PI3K is responsible for the insulin stimulation of GLUT4, the major insulin-regulated glucose transporter from intracellular vesicles to the plasma membrane in insulin-sensitive cells (Frevert et al. <xref ref-type="bibr" rid="CR9">1998</xref>).</p><p>In order to look at the function of AKT1 in pancreatic beta cells, researchers over-expressed constitutively active AKT1 in the &#x003b2;-cells of mice resulting in augmented &#x003b2;-cell mass by an increase in proliferation and cell size (Bernal-Mizrachi et al. <xref ref-type="bibr" rid="CR4">2001</xref>; Tuttle et al. <xref ref-type="bibr" rid="CR34">2001</xref>), and resistance to streptozotocin-induced diabetes (Bernal-Mizrachi et al. <xref ref-type="bibr" rid="CR4">2001</xref>; Tuttle et al. <xref ref-type="bibr" rid="CR34">2001</xref>). Mice with reduced Akt/Pkb activity in &#x003b2;-cells exhibited normal &#x003b2;-cell mass but defective insulin secretion (Bernal-Mizrachi et al. <xref ref-type="bibr" rid="CR5">2004</xref>), and increased susceptibility to developing glucose intolerance and diabetes following fat feeding (Bernal-Mizrachi et al. <xref ref-type="bibr" rid="CR5">2004</xref>). The roles of AKT1 as a key mediator in both muscle hypertrophy and atrophy and insulin signaling and glucose uptake indicate that this gene may play a role in a metabolic phenotypes, specifically the endophenotypes that together lead to metabolic syndrome.</p><p>Thus, we studied the <italic>AKT1</italic> gene as a candidate for metabolic syndrome features. We hypothesized that the use of a young adult population would increase sensitivity for detection of these phenotypes, as all are well-documented to be age-related. Further, each phenotype has many potential environmental influences (lifestyle, training, diet), thus we hypothesize that a college-age population might have fewer potential confounders (Thompson et al. <xref ref-type="bibr" rid="CR33">2004</xref>; Uthurralt et al. <xref ref-type="bibr" rid="CR35">2007</xref>; Zoeller et al. <xref ref-type="bibr" rid="CR40">2007</xref>).</p><p>Here, we report the <italic>AKT1</italic> haplotype structure, including a relatively small region of 12&#x000a0;kb with two predominant haplotypes (H1 and H2) upstream and inclusive of the first exon of the <italic>AKT1</italic> gene. We evaluated a hap-tag SNP (rs1130214) in three population-based cohorts (FAMUSS, SHS, Health ABC), and one cohort focused on insulin resistance and response to training (STRRIDE) (Harris et al. <xref ref-type="bibr" rid="CR12">2005</xref>; Lee et al. <xref ref-type="bibr" rid="CR14">1990</xref>; Slentz et al. <xref ref-type="bibr" rid="CR27">2007</xref>; Thompson et al. <xref ref-type="bibr" rid="CR33">2004</xref>). We show that the H1 12&#x000a0;kb <italic>AKT1</italic> haplotype is significantly associated with higher fasting serum glucose levels, and an increased risk for developing metabolic syndrome.</p></sec><sec id="Sec2"><title>Participants and methods</title><sec id="Sec3"><title>Subject populations</title><sec id="Sec4"><title>FAMUSS population</title><p>The study design of the FAMUSS Study has been reported (Thompson et al. <xref ref-type="bibr" rid="CR33">2004</xref>). Briefly, 574 volunteers (18&#x02013;41&#x000a0;years; mean 23.7&#x000a0;&#x000b1;&#x000a0;5.7) were enrolled into a unilateral supervised 12-week resistance training intervention of the non-dominant arm. Quantified phenotypes included baseline blood pressure, height and weight and serum measurements including HDL, total cholesterol, fasting glucose, fasting insulin, and triglycerides. A dichotomous characterization of metabolic syndrome was defined as fulfilling at least three of the five criteria proposed by NCEP (<xref ref-type="bibr" rid="CR37">2001</xref>). These criteria include an elevated waist circumference, triglycerides, blood pressure, fasting glucose and reduced HDL cholesterol. Because the FAMUSS Study did not collect waist circumference measurements, an elevated BMI (&#x0003e;25) was used as a surrogate.</p></sec><sec id="Sec5"><title>Strong Heart Study</title><p>The SHS is a study of CVD and its risk factors among American Indian men and women (Lee et al. <xref ref-type="bibr" rid="CR14">1990</xref>). Briefly, DNA and serum measurements were collected on 2,134 volunteers (45&#x02013;75&#x000a0;years; mean 55.5&#x000a0;&#x000b1;&#x000a0;7.9). Quantified phenotypes included baseline blood pressure, height and weight and serum measurements including HDL, total cholesterol, fasting glucose, fasting insulin, triglycerides and incidence of metabolic syndrome.</p></sec><sec id="Sec6"><title>Health ABC Study</title><p>Health ABC is a longitudinal study of body composition in older men and women with goals of identifying the clinical conditions that accelerate changes in and examining the health impact of these changes on the diseases of old age (Visser et al. <xref ref-type="bibr" rid="CR36">1999</xref>). Briefly, DNA and serum measurements were collected on 3,075 volunteers (68&#x02013;80&#x000a0;years; mean 73.6&#x000a0;&#x000b1;&#x000a0;2.9). Quantified phenotypes included baseline blood pressure, height and weight and serum measurements including HDL, total cholesterol, fasting glucose and fasting insulin. Triglycerides and incidence of metabolic syndrome and diabetes were classified as dichotomous phenotypes using NCEP ATP III criteria.</p></sec><sec id="Sec7"><title>STRRIDE Study</title><p>The STRRIDE Study is a controlled study designed to measure the effect of exercise on abdominal fat. Briefly, 175 overweight individuals, male and female, aged 40&#x02013;65&#x000a0;years were assigned an 8-month exercise regimen. All participants had mild to moderate lipid abnormalities. They were randomly assigned to one of three exercise groups: (1) high amount/vigorous intensity (65&#x02013;80% of peak oxygen consumption), (2) low amount/vigorous intensity (65&#x02013;80% of peak oxygen consumption), and (3) low amount/moderate intensity (40&#x02013;55% of peak oxygen consumption). Quantified phenotypes included tomography scans of abdominal fat, BMI measures, Sg (glucose-stimulated glucose-release), insulin sensitivity index (ISI) and acute insulin response to glucose (AIRg).</p></sec></sec><sec id="Sec8"><title>Phenotype measures for FAMUSS Study</title><p>Serum measurements were made from stored fasting sera and plasma from each subject (baseline). Measurements: fasting glucose, fasting insulin, C-reactive protein and lipid panel (triglycerides and HDL). All measurements were made by Quest Diagnostics (Chantilly VA).</p></sec><sec id="Sec9"><title>SNP discovery</title><p>SNPs for each exon, exon/intron boundaries, and 10&#x000a0;kb upstream (5&#x02032;) to the <italic>AKT1</italic> gene were identified by screening a panel of 96 ethnically diverse genomic DNA samples with denaturing high performance liquid chromatography (Transgenomic WAVE system, Transgenomic, USA) and automated sequencing (Applied Biosystems 3100 Genetic Analyzer). Polymorphisms were tested for allele frequency, and cross-referenced to dbSNP (<ext-link ext-link-type="uri" xlink:href="http://www.dbSNP.org">http://www.dbSNP.org</ext-link>) and HapMap (<ext-link ext-link-type="uri" xlink:href="http://www.hapmap.org">http://www.hapmap.org</ext-link>) data resources. Twelve SNPs were studied in depth, selected based upon allele frequency and linkage disequilibrium testing. The published sensitivity of DHPLC for SNP detection is 96% (Jones et al. <xref ref-type="bibr" rid="CR13">1999</xref>). However, to reach that level of SNP detection requires optimal temperature selection and possibly primer redesign (Jones et al. <xref ref-type="bibr" rid="CR13">1999</xref>). For this publication, we cannot be certain that we did not miss additional variation in the <italic>AKT1</italic> regions that we scanned due to the level of sensitivity of this technique. In addition, DHPLC suffers from the inability to discover homozygote changes and would require mixing of a sample with a known sequence to all scanned samples for the discovery of homozygous changes (Mogensen et al. <xref ref-type="bibr" rid="CR17">2003</xref>). DHPLC Novel SNPs not in dbSNP or HapMap databases were submitted to dbSNP. A list of the SNPs studied and their respective dbSNP identifiers (including those submitted to dbSNP) can be found in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>.<table-wrap id="Tab1"><label>Table&#x000a0;1</label><caption><p><italic>AKT1</italic> single nucleotide polymorphisms discovered using DHPLC in a 96-individual panel</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">SNP position in <italic>AKT1</italic><sup>a</sup></th><th align="left">SNP rs#</th><th align="left"/></tr></thead><tbody><tr><td align="left">&#x02212;C9756A</td><td align="left">rs33925946</td><td align="left">Novel</td></tr><tr><td align="left">&#x02212;C6148T</td><td align="left">rs4983387</td><td align="left"/></tr><tr><td align="left">&#x02212;C6024T</td><td align="left">rs10141867</td><td align="left"/></tr><tr><td align="left">&#x02212;C5854T</td><td align="left">rs34284721</td><td align="left">Novel</td></tr><tr><td align="left">&#x02212;C832G</td><td align="left">rs2494750</td><td align="left"/></tr><tr><td align="left">+G1780A</td><td align="left">rs28634999</td><td align="left">Novel</td></tr><tr><td align="left">+G2347T</td><td align="left">rs1130214</td><td align="left"/></tr><tr><td align="left">+G2375A</td><td align="left">rs10138227</td><td align="left"/></tr><tr><td align="left">+A15756T</td><td align="left">rs2494737</td><td align="left"/></tr><tr><td align="left">+G20703A</td><td align="left">rs3730346</td><td align="left"/></tr><tr><td align="left">+A22889G</td><td align="left">rs2494732</td><td align="left"/></tr><tr><td align="left">+G23477A</td><td align="left">rs2498800</td><td align="left"/></tr></tbody></table><table-wrap-foot><p><sup>a</sup>Numbering based on Genbank NM_001014431.1</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec10"><title>Genotyping</title><p>Genotyping was done using a novel TaqMan allele discrimination assay that employs the 5&#x02032; nuclease activity of Taq polymerase to detect a fluorescent reporter signal generated during PCR reactions (see Supplemental Table&#x000a0;1). Both alleles were detected simultaneously using allele-specific oligonucleotides labeled with different fluorophores, and genotypes determined by the ratio of the two fluorophores used. Allele-specific PCR reactions for each SNP included 10&#x000a0;ng genomic DNA, 900&#x000a0;nM forward and reverse PCR primers, 200&#x000a0;nM fluorescent allele discrimination probes (common allele FAM labeled; rare allele VIC labeled) and TaqMan<sup>&#x000ae;</sup> Universal PCR Master Mix, No AmpErase<sup>&#x000ae;</sup> UNG [Applied Biosystems (ABI), Foster City, CA, USA] in a final volume of 10&#x000a0;&#x003bc;l. The PCR and fluorescent ratio profile was done using 10&#x000a0;min at 95&#x000b0;C (denaturation), and 44 cycles of 15&#x000a0;s at 92&#x000b0;C and 1&#x000a0;min at an annealing temperature of 60&#x000b0;C. Reactions were set up using a MWG robot, and fluorescence ratios and allele calling done using an ABI 7900.</p></sec><sec id="Sec11"><title>Linkage disequilibrium</title><p>Pair-wise tests for linkage disequilibrium were done for all 12 <italic>AKT1</italic> polymorphisms using the correlation coefficient (<italic>R</italic>) on each pair-wise combination in the 1,078 FAMUSS subjects. A haplotype minimization algorithm contained within the PHASE v 2.1 program (Stephens et al. <xref ref-type="bibr" rid="CR28">2001</xref>) was then used to establish haplotypes from these data.</p></sec><sec id="Sec12"><title>Statistical methods</title><p>Hardy&#x02013;Weinberg equilibrium was determined for each SNP using a <italic>&#x003c7;</italic><sup>2</sup> test to compare the observed genotype frequencies to those expected under H&#x02013;W equilibrium. All genotyped SNPs were in H&#x02013;W equilibrium.</p><p>All metabolic syndrome-related phenotypes were analyzed as either continuous quantitative traits (triglycerides, fasting glucose, etc.) or as dichotomous traits (metabolic syndrome and high/low triglyceride level). Normality of each quantitative trait was confirmed using the Shapiro&#x02013;Wilk normality test.</p><p>Bivariate correlation analyses of each quantitative measurement showed several significant correlations with age and baseline mass; therefore, associations between each SNP and quantitative phenotype were assessed using analysis of covariance (ANCOVA) methods. Due to large gender differences all analyses were performed separately for males and females.</p><p>Each ANCOVA used a dominant genetic model statistically comparing the group of homozygous wild-type individuals to the group of heterozygous and homozygous mutant individuals.</p><p>Linear regression analysis, including likelihood ratio tests between full (containing genotype and covariates) and constrained (containing covariates only) models, were performed to estimate the proportion of variance in volumetric measurements attributable to each SNP&#x02019;s genotype. For dichotomous traits, logistic regression models adjusted for age and baseline body mass were used. A nominal <italic>p</italic> value of 0.05 was defined as significant and all statistical analyses were performed using Stata V.8 (StataCorp, College Park, TX).</p></sec></sec><sec id="Sec13"><title>Results</title><sec id="Sec14"><title>SNP discovery and haplotypes of <italic>AKT1</italic></title><p>SNPs for each exon, exon/intron boundaries, and 10&#x000a0;kb upstream (5&#x02032;) to the <italic>AKT1</italic> gene (Genbank NM_001014431.1) were identified by screening a panel of 96 ethnically diverse genomic DNA samples with denaturing high performance liquid chromatography and automated sequencing. We identified 12 SNPs in <italic>AKT1</italic>, 7 of which were intragenic and 5 of which were upstream of the gene. A list of the SNPs studied and their respective dbSNP identifiers (including three novel SNPs submitted to dbSNP) can be found in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>.</p><p>The SNPs were genotyped in the FAMUSS population (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>) to identify regions that showed strong linkage disequilibrium to test in additional populations. Two major haplotype blocks were identified, one including most of the coding region of the gene and one 12&#x000a0;kb haplotype upstream of <italic>AKT1</italic> inclusive of the first exon, haplotype H1/H2. The H1/H2 haplotype is composed of SNPs: rs1130214, rs10141867 and rs33925946. The H1 haplotype alleles are GCC for those three SNPs; the H2 haplotype alleles are TTA for those three SNPs (on the plus strand DNA). LD plots were generated showing the extent of LD between the SNPs listed in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>. The SNPs of haplotype H1/H2 are shown in red text. The amount of LD between any two SNPs (plotted on the <italic>X</italic> and <italic>Y</italic> axis) as determined by the correlation coefficient <italic>R</italic> is shown on a color scale from blue to red. Blue equals <italic>r</italic><sup>2</sup> of zero, or no LD; red equals <italic>r</italic><sup>2</sup> of 1 or perfect LD (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>). SNP rs10138227 shows some LD with the other three but it is not strong enough to include as part of the haplotype. From this work, we chose to analyze rs1130214 as a hap-tag SNP representing a 12&#x000a0;kb haplotype covering the first intron/10&#x000a0;kb upstream.<table-wrap id="Tab2"><label>Table&#x000a0;2</label><caption><p>Characteristics of the FAMUSS cohort</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Characteristic</th><th align="left" colspan="2">Females</th><th align="left" colspan="2">Males</th></tr><tr><th align="left"><italic>N</italic></th><th align="left">Mean&#x000a0;&#x000b1;&#x000a0;SD</th><th align="left"><italic>N</italic></th><th align="left">Mean&#x000a0;&#x000b1;&#x000a0;SD</th></tr></thead><tbody><tr><td align="left">Age (years)</td><td align="left">359</td><td char="&#x000b1;" align="char">23.58&#x000a0;&#x000b1;&#x000a0;5.62</td><td char="&#x000b1;" align="char">215</td><td char="&#x000b1;" align="char">24.29&#x000a0;&#x000b1;&#x000a0;5.90</td></tr><tr><td align="left">Weight (kg)</td><td align="left">359</td><td char="&#x000b1;" align="char">65.3&#x000a0;&#x000b1;&#x000a0;12.8</td><td char="&#x000b1;" align="char">215</td><td char="&#x000b1;" align="char">81.2&#x000a0;&#x000b1;&#x000a0;17.2</td></tr><tr><td align="left">Height (cm)</td><td align="left">359</td><td char="&#x000b1;" align="char">165&#x000a0;&#x000b1;&#x000a0;6.8</td><td char="&#x000b1;" align="char">215</td><td char="&#x000b1;" align="char">177.8&#x000a0;&#x000b1;&#x000a0;6.8</td></tr><tr><td align="left">BMI</td><td align="left">359</td><td char="&#x000b1;" align="char">23.94&#x000a0;&#x000b1;&#x000a0;4.66</td><td char="&#x000b1;" align="char">215</td><td char="&#x000b1;" align="char">25.61&#x000a0;&#x000b1;&#x000a0;5.15</td></tr></tbody></table></table-wrap><fig id="Fig1"><label>Fig.&#x000a0;1</label><caption><p>Linkage disequilibrium among <italic>AKT1</italic> SNPs within the FAMUSS population and SHS. Linkage disequilibrium is plotted for African-Americans, Asians and European Americans of the FMS cohort. The LD was calculated between each pair of SNPs using the <italic>r</italic><sup>2</sup> measurement and haplotype frequencies were estimated using the online program PHASE, which uses genotype data to determine the phase of the chromosomes and thus haplotype structure and frequency. The SNPs from Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref> are plotted on the <italic>X</italic> and <italic>Y</italic> axes. A color scale is then used to plot the LD between any two SNPs. <italic>Blue</italic> equals an <italic>r</italic><sup>2</sup> of zero, <italic>red</italic> equals an <italic>r</italic><sup>2</sup> of 1.0. The SNPs of H1/H2 are in <italic>red</italic> text. All three of the SNPs are in high LD with each other as shown by the <italic>red blocks</italic></p></caption><graphic xlink:href="439_2010_910_Fig1_HTML" id="MO1"/></fig></p></sec><sec id="Sec15"><title>Associations between <italic>AKT1</italic> and the FAMUSS, Strong Heart Study, Health ABC and STRRIDE studies</title><p>We used the young adult FAMUSS population to screen for associations between the <italic>AKT1</italic> gene polymorphisms of the H1/H2 haplotype and metabolic syndrome endophenotypes: increased adiposity, increased blood pressure, low serum HDL, insulin resistance and fasting glucose levels, with subsequent validation of associations in additional population-based cohorts (SHS, Health ABC) and in the insulin resistant population STRRIDE (demographics of these four populations are shown in Tables&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>, <xref rid="Tab3" ref-type="table">3</xref>, <xref rid="Tab4" ref-type="table">4</xref>, <xref rid="Tab5" ref-type="table">5</xref>).<table-wrap id="Tab3"><label>Table&#x000a0;3</label><caption><p>Characteristics of the Strong Heart cohort</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Characteristic</th><th align="left">Females (<italic>N</italic>&#x000a0;=&#x000a0;1,349)</th><th align="left">Males (<italic>N</italic>&#x000a0;=&#x000a0;785)</th></tr></thead><tbody><tr><td align="left" colspan="3">Tribe</td></tr><tr><td align="left">&#x000a0;Arizona</td><td align="left">724</td><td align="left">357</td></tr><tr><td align="left">&#x000a0;South Dakota</td><td align="left">625</td><td align="left">428</td></tr><tr><td align="left">Age (years)</td><td align="left">56.19&#x000a0;&#x000b1;&#x000a0;7.87</td><td align="left">55.45&#x000a0;&#x000b1;&#x000a0;7.66</td></tr><tr><td align="left">Weight (kg)</td><td align="left">81.11&#x000a0;&#x000b1;&#x000a0;17.10</td><td align="left">89.37&#x000a0;&#x000b1;&#x000a0;19.33</td></tr><tr><td align="left">Height (cm)</td><td align="left">159.47&#x000a0;&#x000b1;&#x000a0;5.66</td><td align="left">173.14&#x000a0;&#x000b1;&#x000a0;6.35</td></tr><tr><td align="left">BMI</td><td align="left">31.89&#x000a0;&#x000b1;&#x000a0;6.52</td><td align="left">29.78&#x000a0;&#x000b1;&#x000a0;6.07</td></tr></tbody></table></table-wrap><table-wrap id="Tab4"><label>Table&#x000a0;4</label><caption><p>Characteristics of the Health ABC cohort</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Characteristic</th><th align="left" colspan="2">African-Americans</th><th align="left" colspan="2">Caucasians</th></tr><tr><th align="left">Females (<italic>N</italic>&#x000a0;=&#x000a0;729)</th><th align="left">Males (<italic>N</italic>&#x000a0;=&#x000a0;552)</th><th align="left">Females (<italic>N</italic>&#x000a0;=&#x000a0;855)</th><th align="left">Males (<italic>n</italic>&#x000a0;=&#x000a0;939)</th></tr></thead><tbody><tr><td align="left" colspan="5">Site</td></tr><tr><td align="left">&#x000a0;Memphis</td><td align="left">337</td><td align="left">276</td><td align="left">459</td><td align="left">476</td></tr><tr><td align="left">&#x000a0;Pittsburgh</td><td align="left">392</td><td align="left">276</td><td align="left">396</td><td align="left">463</td></tr><tr><td align="left">Age (years)</td><td align="left">73.37&#x000a0;&#x000b1;&#x000a0;2.95</td><td align="left">73.51&#x000a0;&#x000b1;&#x000a0;2.78</td><td align="left">73.60&#x000a0;&#x000b1;&#x000a0;2.79</td><td align="left">73.92&#x000a0;&#x000b1;&#x000a0;2.92</td></tr><tr><td align="left">Weight (kg)</td><td align="left">75.60&#x000a0;&#x000b1;&#x000a0;15.76</td><td align="left">81.44&#x000a0;&#x000b1;&#x000a0;14.73</td><td align="left">66.25&#x000a0;&#x000b1;&#x000a0;12.21</td><td align="left">81.36&#x000a0;&#x000b1;&#x000a0;12.38</td></tr><tr><td align="left">BMI</td><td align="left">29.66&#x000a0;&#x000b1;&#x000a0;5.86</td><td align="left">27.18&#x000a0;&#x000b1;&#x000a0;4.40</td><td align="left">26.03&#x000a0;&#x000b1;&#x000a0;4.54</td><td align="left">27.00&#x000a0;&#x000b1;&#x000a0;3.68</td></tr></tbody></table></table-wrap><table-wrap id="Tab5"><label>Table&#x000a0;5</label><caption><p>Characteristics of the STRIDDE cohort</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Characteristic</th><th align="left" colspan="2">African-Americans</th><th align="left" colspan="2">Caucasians</th></tr><tr><th align="left">Females (<italic>N</italic>&#x000a0;=&#x000a0;52)</th><th align="left">Males (<italic>N</italic>&#x000a0;=&#x000a0;32)</th><th align="left">Females (<italic>N</italic>&#x000a0;=&#x000a0;139)</th><th align="left">Males (<italic>n</italic>&#x000a0;=&#x000a0;154)</th></tr></thead><tbody><tr><td align="left">Age (years)</td><td char="&#x000b1;" align="char">50.17&#x000a0;&#x000b1;&#x000a0;4.66</td><td char="&#x000b1;" align="char">49.03&#x000a0;&#x000b1;&#x000a0;6.18</td><td char="&#x000b1;" align="char">54.93&#x000a0;&#x000b1;&#x000a0;5.14</td><td char="&#x000b1;" align="char">50.44&#x000a0;&#x000b1;&#x000a0;7.04</td></tr><tr><td align="left">Weight (kg)</td><td char="&#x000b1;" align="char">85.89&#x000a0;&#x000b1;&#x000a0;12.67</td><td char="&#x000b1;" align="char">96.74&#x000a0;&#x000b1;&#x000a0;13.67</td><td char="&#x000b1;" align="char">78.34&#x000a0;&#x000b1;&#x000a0;10.75</td><td char="&#x000b1;" align="char">95.68&#x000a0;&#x000b1;&#x000a0;12.28</td></tr><tr><td align="left">Height (cm)</td><td char="&#x000b1;" align="char">163.39&#x000a0;&#x000b1;&#x000a0;6.83</td><td char="&#x000b1;" align="char">176/02&#x000a0;&#x000b1;&#x000a0;7.98</td><td char="&#x000b1;" align="char">163.22&#x000a0;&#x000b1;&#x000a0;6.19</td><td char="&#x000b1;" align="char">177.95&#x000a0;&#x000b1;&#x000a0;5.83</td></tr><tr><td align="left">BMI</td><td char="&#x000b1;" align="char">32.07&#x000a0;&#x000b1;&#x000a0;3.46</td><td char="&#x000b1;" align="char">31.20&#x000a0;&#x000b1;&#x000a0;3.73</td><td char="&#x000b1;" align="char">29.36&#x000a0;&#x000b1;&#x000a0;3.25</td><td char="&#x000b1;" align="char">30.14&#x000a0;&#x000b1;&#x000a0;2.91</td></tr></tbody></table></table-wrap></p><p>The SNP association analyses were done with both heterozygotes (GT) and homozygotes for the T allele (TT) in the same group because the number of TT individuals was too low in some groups to see an effect. Therefore, the analyses are interpreted as associations with at least one copy of the T allele (H2) versus homozygotes for the G allele (H1).</p><p>The H1/H2 hap-tag SNP rs1130214 was associated with fasting glucose only in females and this SNP contributed 1.3% to genotypic variance (Table&#x000a0;<xref rid="Tab6" ref-type="table">6</xref>). SNP rs1130214 causes a G to T change (representing the H1 and H2 haplotypes, respectively). With at least one copy of the T allele, females had lower values of fasting glucose (GG, <italic>N</italic>&#x000a0;=&#x000a0;201; 86.22&#x000a0;&#x000b1;&#x000a0;0.50&#x000a0;mg/dL vs. GT/TT, <italic>N</italic>&#x000a0;=&#x000a0;178; 84.55&#x000a0;&#x000b1;&#x000a0;0.53 mg/dL; <italic>p</italic>&#x000a0;=&#x000a0;0.0236). This SNP did not have any associations with any metabolic syndrome endophenotypes in males in the FAMUSS Study.<table-wrap id="Tab6"><label>Table&#x000a0;6</label><caption><p>Association of the T allele of rs1130214 in FAMUSS with decreased glucose</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">SNP</th><th align="left">Phenotype</th><th align="left">Gender</th><th align="left"><italic>N</italic>, adjusted mean&#x000a0;&#x000b1;&#x000a0;SEM</th><th align="left"><italic>p</italic> value</th><th align="left">% variation attributable to genotype</th></tr></thead><tbody><tr><td align="left">rs1130214</td><td align="left">Fasting glucose</td><td align="left">Female</td><td align="left">GG (<italic>N</italic>&#x000a0;=&#x000a0;201; 86.22&#x000a0;&#x000b1;&#x000a0;0.50)<break/>GT/TT (<italic>N</italic>&#x000a0;=&#x000a0;178; 84.55&#x000a0;&#x000b1;&#x000a0;0.53)</td><td align="left">0.0236</td><td align="left">1.3%</td></tr></tbody></table></table-wrap></p><p>We then used rs1130214 as a hap-tag SNP, and genotyped both Strong Heart Study (Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>) and Health ABC (Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref>) to test for any associations with metabolic phenotypes in older cohorts. For the older and more heterogeneous Strong Heart Study population of Native Americans, rs1130214 showed association with 2-h glucose, fasting insulin, triglycerides, and the HOMA measure of insulin resistance in males (Table&#x000a0;<xref rid="Tab7" ref-type="table">7</xref>). The T allele was associated with lower 2&#x000a0;h glucose levels (GG, <italic>N</italic>&#x000a0;=&#x000a0;434; 180.69&#x000a0;&#x000b1;&#x000a0;5.11&#x000a0;mg/dL vs. GT/TT, <italic>N</italic>&#x000a0;=&#x000a0;147; 160.01&#x000a0;&#x000b1;&#x000a0;8.77&#x000a0;mg/dL; <italic>p</italic>&#x000a0;=&#x000a0;0.0422) and lower fasting insulin (GG, <italic>N</italic>&#x000a0;=&#x000a0;564; 19.44&#x000a0;&#x000b1;&#x000a0;0.68&#x000a0;&#x003bc;IU/mL vs. GT/TT, <italic>N</italic>&#x000a0;=&#x000a0;208; 16.21&#x000a0;&#x000b1;&#x000a0;1.12&#x000a0;&#x003bc;IU/mL; <italic>p</italic>&#x000a0;=&#x000a0;0.0136). In addition, in males, the T allele was associated with a lower HOMA value (GG, <italic>N</italic>&#x000a0;=&#x000a0;559; 7.52&#x000a0;&#x000b1;&#x000a0;0.32 vs. GT/TT, <italic>N</italic>&#x000a0;=&#x000a0;203; 6.15&#x000a0;&#x000b1;&#x000a0;0.53; <italic>p</italic>&#x000a0;=&#x000a0;0.267).<table-wrap id="Tab7"><label>Table&#x000a0;7</label><caption><p>Association of the T allele of rs1130214 in SHS with parameters of metabolic syndrome</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">SNP</th><th align="left">Phenotype</th><th align="left">Gender</th><th align="left"><italic>N</italic>, adjusted mean&#x000a0;&#x000b1;&#x000a0;SEM</th><th align="left"><italic>p</italic> value</th><th align="left">% variation attributable to genotype</th></tr></thead><tbody><tr><td align="left" rowspan="2">rs1130214</td><td align="left" rowspan="2">BMI</td><td align="left" rowspan="2">Female</td><td align="left">GG (<italic>N</italic>&#x000a0;=&#x000a0;1,131; 31.87&#x000a0;&#x000b1;&#x000a0;0.19)</td><td align="left" rowspan="2">0.0271</td><td char="." align="char" rowspan="2">0.3</td></tr><tr><td align="left">GT/TT (<italic>N</italic>&#x000a0;=&#x000a0;396; 31.04&#x000a0;&#x000b1;&#x000a0;0.32)</td></tr><tr><td align="left" rowspan="2">rs1130214</td><td align="left" rowspan="2">2&#x000a0;h glucose</td><td align="left" rowspan="2">Male</td><td align="left">GG (<italic>N</italic>&#x000a0;=&#x000a0;434; 180.69&#x000a0;&#x000b1;&#x000a0;5.11)</td><td align="left" rowspan="2">0.0422</td><td char="." align="char" rowspan="2">0.7</td></tr><tr><td align="left">GT/TT (<italic>N</italic>&#x000a0;=&#x000a0;147; 160.01&#x000a0;&#x000b1;&#x000a0;8.77)</td></tr><tr><td align="left" rowspan="2">rs1130214</td><td align="left" rowspan="2">Fasting insulin</td><td align="left" rowspan="2">Male</td><td align="left">GG (<italic>N</italic>&#x000a0;=&#x000a0;564; 19.44&#x000a0;&#x000b1;&#x000a0;0.68)</td><td align="left" rowspan="2">0.0136</td><td char="." align="char" rowspan="2">0.6</td></tr><tr><td align="left">GT/TT (<italic>N</italic>&#x000a0;=&#x000a0;208; 16.21&#x000a0;&#x000b1;&#x000a0;1.12)</td></tr><tr><td align="left" rowspan="2">rs1130214</td><td align="left" rowspan="2">Triglycerides</td><td align="left" rowspan="2">Male</td><td align="left">GG (<italic>N</italic>&#x000a0;=&#x000a0;565; 142.66&#x000a0;&#x000b1;&#x000a0;9.92)</td><td align="left" rowspan="2">0.0141</td><td char="." align="char" rowspan="2">0.8</td></tr><tr><td align="left">GT/TT (<italic>N</italic>&#x000a0;=&#x000a0;208; 189.74&#x000a0;&#x000b1;&#x000a0;16.35)</td></tr><tr><td align="left" rowspan="2">rs1130214</td><td align="left" rowspan="2">HOMA</td><td align="left" rowspan="2">Male</td><td align="left">GG (<italic>N</italic>&#x000a0;=&#x000a0;559; 7.52&#x000a0;&#x000b1;&#x000a0;0.32)</td><td align="left" rowspan="2">0.0267</td><td char="." align="char" rowspan="2">0.6</td></tr><tr><td align="left">GT/TT (<italic>N</italic>&#x000a0;=&#x000a0;203; 6.15&#x000a0;&#x000b1;&#x000a0;0.53)</td></tr></tbody></table></table-wrap></p><p>In male participants in the Health ABC Study, the T allele of rs1130214 was associated with lower fasting glucose (GG, <italic>N</italic>&#x000a0;=&#x000a0;661; 110.5&#x000a0;&#x000b1;&#x000a0;1.4&#x000a0;mg/dL vs. GT/TT, <italic>N</italic>&#x000a0;=&#x000a0;798; 106.4&#x000a0;&#x000b1;&#x000a0;1.3&#x000a0;mg/dL; <italic>p</italic>&#x000a0;=&#x000a0;0.0305) (Table&#x000a0;<xref rid="Tab8" ref-type="table">8</xref>). This effect was also seen in African-Americans males (GG, <italic>N</italic>&#x000a0;=&#x000a0;205; 116.8&#x000a0;&#x000b1;&#x000a0;2.9&#x000a0;mg/dL vs. GT/TT, <italic>N</italic>&#x000a0;=&#x000a0;328; 107.7&#x000a0;&#x000b1;&#x000a0;2.3&#x000a0;mg/dL; <italic>p</italic>&#x000a0;=&#x000a0;0.0170). These results are not significant after correction for multiple testing (<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.007); however, the statistical community is divided on correction methods for multiple testing since the Bonferonni correction may be too harsh and thus increasing false negatives (Rice et al. <xref ref-type="bibr" rid="CR21">2008</xref>).<table-wrap id="Tab8"><label>Table&#x000a0;8</label><caption><p>Association of the T allele of rs1130214 in HABC cohort with decreased fasting glucose</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">SNP</th><th align="left">Phenotype</th><th align="left">Gender/Ethnicity</th><th align="left"><italic>N</italic>, Adjusted mean&#x000a0;&#x000b1;&#x000a0;SEM</th><th align="left"><italic>p</italic> value</th><th align="left">% variation attributable to genotype</th></tr></thead><tbody><tr><td align="left" rowspan="2">rs1130214</td><td align="left" rowspan="2">Fasting glucose</td><td align="left" rowspan="2">All males</td><td align="left">GG (<italic>N</italic>&#x000a0;=&#x000a0;661; 110.5&#x000a0;&#x000b1;&#x000a0;1.4)*</td><td align="left" rowspan="2">*<italic>p</italic>&#x000a0;=&#x000a0;0.0305</td><td char="." align="char" rowspan="2">0.3</td></tr><tr><td align="left">GT/TT (<italic>N</italic>&#x000a0;=&#x000a0;798; 106.4&#x000a0;&#x000b1;&#x000a0;1.3)*</td></tr><tr><td align="left" rowspan="2">rs1130214</td><td align="left" rowspan="2">Fasting glucose</td><td align="left" rowspan="2">African-American males</td><td align="left">GG (<italic>N</italic>&#x000a0;=&#x000a0;205; 116.8&#x000a0;&#x000b1;&#x000a0;2.9)*</td><td align="left" rowspan="2">*<italic>p</italic>&#x000a0;=&#x000a0;0.0170</td><td char="." align="char" rowspan="2">1.1</td></tr><tr><td align="left">GT/TT (<italic>N</italic>&#x000a0;=&#x000a0;328; 107.7&#x000a0;&#x000b1;&#x000a0;2.3)*</td></tr></tbody></table></table-wrap></p><p>Taken together, associations from all three population-based cohorts suggested that the <italic>AKT1</italic> upstream haplotype was a determinant of insulin resistance, resulting in higher circulating glucose and/or insulin with apparent age- and sex-dependence.</p></sec><sec id="Sec16"><title>Associations between <italic>AKT1</italic> rs1130214 and the Health ABC Study for metabolic syndrome</title><p>The five commonly accepted endophenotypes of metabolic syndrome are: increased insulin resistance or fasting glucose plasma levels (&#x0003e;100&#x000a0;mg/dl), increased adiposity (central obesity or BMI&#x000a0;&#x0003e;&#x000a0;30), elevated triglycerides (equal to or greater than 150&#x000a0;mg/dL), increased blood pressure (&#x0003e;130mmHg/85mmHg), and low serum HDL (&#x0003c;40&#x02013;50&#x000a0;mg/dl) (Alberti et al. <xref ref-type="bibr" rid="CR3">2006</xref>; Alberti and Zimmet <xref ref-type="bibr" rid="CR2">1998</xref>; Grundy et al. <xref ref-type="bibr" rid="CR10">2004</xref>; NCEP <xref ref-type="bibr" rid="CR37">2001</xref>). To determine if the H1/H2 haplotype is a major determinant of metabolic syndrome diagnosis, we studied the Health ABC population. This population-based study had a diagnosis of T2D as an exclusion criterion, with excellent phenotyping of metabolic syndrome endophenotypes in a tightly restricted age range (Harris et al. <xref ref-type="bibr" rid="CR12">2005</xref>).</p><p>The incidence of metabolic syndrome showed a significant association with rs1130214 in the Health ABC population (Table&#x000a0;<xref rid="Tab9" ref-type="table">9</xref>). The analysis was done for both heterozygotes (GT) and homozygotes for the T allele (TT) because the number of TT individuals was too low for some groups to determine any effect. We saw strong effects with having at least one copy of the T allele suggesting that haplotype H2 strongly influences these phenotypes even in the presence of one copy of the H1 haplotype (represented by the G allele). Individuals with at least one copy of the T allele were much less likely to have metabolic syndrome, consistent with the lower insulin resistance observed with the T allele (H2) in all three cohorts. This was true for the entire Health ABC cohort (GT/TT: OR&#x000a0;=&#x000a0;0.765, <italic>p</italic>&#x000a0;=&#x000a0;0.001) and all males (GT/TT: OR&#x000a0;=&#x000a0;0.650, <italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.001). There was a significant effect in all females for the TT individuals only (TT, OR&#x000a0;=&#x000a0;0.577; <italic>p</italic>&#x000a0;=&#x000a0;0.005). The T allele showed a very strong protective effect in African-American males (GT, OR&#x000a0;=&#x000a0;0.539; <italic>p</italic>&#x000a0;=&#x000a0;0.007). These results are significant after correction for multiple testing (<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.007).<table-wrap id="Tab9"><label>Table&#x000a0;9</label><caption><p>The T allele of rs1130214 is protective of metabolic syndrome in HABC cohort</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Group</th><th align="left">rs1130214 genotype</th><th align="left"><italic>N</italic> (controls)</th><th align="left"><italic>N</italic> (metabolic syndrome)</th><th align="left">Odds ratio</th><th align="left"><italic>p</italic> value</th><th align="left">95% confidence interval</th></tr></thead><tbody><tr><td align="left" rowspan="2">All subjects</td><td align="left">GG</td><td char="." align="char">812</td><td char="." align="char">566</td><td char="." align="char">1.00</td><td align="left"/><td align="left"/></tr><tr><td align="left">GT/TT</td><td char="." align="char">1,028</td><td char="." align="char">586</td><td char="." align="char">0.765</td><td char="." align="char">0.001</td><td char="&#x02013;" align="char">0.655&#x02013;0.894</td></tr><tr><td align="left" rowspan="2">All males</td><td align="left">GG</td><td char="." align="char">408</td><td char="." align="char">251</td><td char="." align="char">1.00</td><td align="left"/><td align="left"/></tr><tr><td align="left">GT/TT</td><td char="." align="char">522</td><td char="." align="char">244</td><td char="." align="char">0.650</td><td char="." align="char">&#x0003c;0.001</td><td char="&#x02013;" align="char">0.512&#x02013;0.826</td></tr><tr><td align="left" rowspan="2">Caucasian males</td><td align="left">GG</td><td char="." align="char">275</td><td char="." align="char">179</td><td char="." align="char">1.00</td><td align="left"/><td align="left"/></tr><tr><td align="left">GT/TT</td><td char="." align="char">300</td><td char="." align="char">169</td><td char="." align="char">0.849</td><td char="." align="char">0.050</td><td char="&#x02013;" align="char">0.558&#x02013;1.000</td></tr><tr><td align="left" rowspan="2">African-American males</td><td align="left">GG</td><td char="." align="char">133</td><td char="." align="char">72</td><td char="." align="char">1.00</td><td align="left"/><td align="left"/></tr><tr><td align="left">GT/TT</td><td char="." align="char">252</td><td char="." align="char">75</td><td char="." align="char">0.545</td><td char="." align="char">0.005</td><td char="&#x02013;" align="char">0.357&#x02013;0.834</td></tr><tr><td align="left" rowspan="2">All females</td><td align="left">GG</td><td char="." align="char">404</td><td char="." align="char">325</td><td char="." align="char">1.00</td><td align="left"/><td align="left"/></tr><tr><td align="left">GT/TT</td><td char="." align="char">476</td><td char="." align="char">342</td><td char="." align="char">0.854</td><td char="." align="char">0.151</td><td char="&#x02013;" align="char">0.689&#x02013;1.059</td></tr><tr><td align="left" rowspan="2">Caucasian females</td><td align="left">GG</td><td char="." align="char">236</td><td char="." align="char">186</td><td char="." align="char">1.00</td><td align="left"/><td align="left"/></tr><tr><td align="left">GT/TT</td><td char="." align="char">244</td><td char="." align="char">167</td><td char="." align="char">0.804</td><td char="." align="char">0.148</td><td char="&#x02013;" align="char">0.598&#x02013;1.080</td></tr><tr><td align="left" rowspan="2">African-American females</td><td align="left">GG</td><td char="." align="char">168</td><td char="." align="char">129</td><td char="." align="char">1.00</td><td align="left"/><td align="left"/></tr><tr><td align="left">GT/TT</td><td char="." align="char">232</td><td char="." align="char">175</td><td char="." align="char">0.978</td><td char="." align="char">0.894</td><td char="&#x02013;" align="char">0.712&#x02013;1.346</td></tr></tbody></table></table-wrap></p></sec><sec id="Sec17"><title>Associations between rs1130214 and the STRRIDE Study for glucose-stimulated glucose-release (Sg) levels</title><p>The STRRIDE Study is a cohort of insulin-resistant middle-aged adults. The H2 haplotype (the T allele of rs1130214) was associated with higher Sg in European American males (TT, <italic>p</italic>&#x000a0;=&#x000a0;0.021) (Table&#x000a0;<xref rid="Tab10" ref-type="table">10</xref>). This is consistent with the other cohorts and H2 associations with insulin resistance phenotypes and even protection against metabolic syndrome, which often follows the development of insulin resistance. There were no significant associations (denoted as NS) with any other group of this cohort (Table&#x000a0;<xref rid="Tab10" ref-type="table">10</xref>).<table-wrap id="Tab10"><label>Table&#x000a0;10</label><caption><p>The T allele of rs1130214 was associated with higher Sg in the STRRIDE cohort</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1">Phenotype</th><th align="left">Cohort</th><th align="left"><italic>F</italic> test</th><th align="left"><italic>p</italic> value</th></tr></thead><tbody><tr><td align="left" rowspan="4">Baseline Sg</td><td align="left">Caucasian males</td><td char="." align="char">4.06</td><td align="left">0.021*</td></tr><tr><td align="left">African-American males</td><td char="." align="char">1.01</td><td align="left">NS</td></tr><tr><td align="left">Caucasian females</td><td char="." align="char">1.28</td><td align="left">NS</td></tr><tr><td align="left">African-American females</td><td char="." align="char">2.97</td><td align="left">NS</td></tr></tbody></table></table-wrap></p></sec></sec><sec id="Sec18"><title>Discussion</title><p>We defined the haplotype structure of the <italic>AKT1</italic> gene and studied 12 representative SNPs in a young adult population to identify genetic predispositions to endophenotypes of metabolic syndrome. We identified a relatively small 12&#x000a0;kb haplotype, defined by the SNPs rs1130214, rs10141867 and rs33925946, which are in very strong linkage disequilibrium in all populations studied. In the young adult population (FAMUSS Study), the ancestral haplotype of the 12&#x000a0;kb region (H1; tagged by rs1130214) was associated with higher fasting glucose in females (average age 24&#x000a0;years), suggesting that the 12&#x000a0;kb haplotype is associated with insulin resistance. We validated this finding first in an older and more heterogeneous Native American population (SHS; average age 56&#x000a0;years), where H1 had higher fasting serum glucose, higher serum insulin, and a higher HOMA value in males, all consistent with association with insulin resistance. Although we originally identified an association with fasting glucose levels in the FAMUSS females, we did not see this same association in the older females of the SHS or Health ABC. We then studied a cohort of aged African-American and European American (Health ABC; average age 73&#x000a0;years), and also found evidence for association with insulin resistance, where men with H1 showed higher fasting glucose.</p><p>Insulin resistance is one of the five key endophenotypes associated with T2D, and the precursor state of metabolic syndrome. The diagnosis of metabolic syndrome is made when a subject shows increased visceral adiposity, and two additional threshold phenotypes [increased insulin resistance, increased blood pressure, increased triglycerides (TGs), and low HDL serum levels]. Insulin resistance is a complex physiological and biochemical phenotype involving responses to increased serum glucose by the pancreas, muscle, and liver. The individual components of pancreas, muscle and liver can be resolved by an IVGTT. We studied the association of the 12&#x000a0;kb upstream haplotype with the IVGTT data from STRRIDE subjects with features of metabolic syndrome, and found evidence for association with the Sg phenotype. Thus, four distinct cohorts all validated association of the upstream <italic>AKT1</italic> 12&#x000a0;kb haplotype (H1) with increased insulin resistance; H2 associates with decreased insulin resistance.</p><p>Given the association of the 12&#x000a0;kb <italic>AKT1</italic> upstream haplotype with measures of insulin resistance in four cohorts, we queried the association of the same haplotype with metabolic syndrome diagnosis. It is important to note that the H1 haplotype is the more common haplotype in all populations, and thus associations of a common haplotype with a rare trait become more challenging statistically. Of the four populations studied, only one was felt to be adequate for testing of metabolic syndrome associations, namely the Health ABC Study. The FAMUSS Study population was too young to have an appreciable incidence of metabolic syndrome. The Strong Heart Study was quite heterogeneous in age and showed a very high incidence of many comorbidities associated with metabolic syndrome. The STRRIDE Study was a non-population based study, where participants were recruited based upon having features of metabolic syndrome. However, the Health ABC Study was of large size (<italic>n</italic>&#x000a0;=&#x000a0;3,000), with tightly restricted age (73.6&#x000a0;years), with metabolic syndrome as a key focus of the study. Genotyping of the upstream haplotype in Health ABC showed a very strong association with metabolic syndrome diagnosis (Table&#x000a0;<xref rid="Tab9" ref-type="table">9</xref>). Homozygotes for the ancestral H1 haplotype (GG) had double the risk of metabolic syndrome compared to those homozygous for the less common H2 haplotype (TT). This association was retained when the population was stratified by sex and ethnicity.</p><p>Along with protection from metabolic syndrome, the <italic>AKT1</italic> H2 haplotype was associated with higher values of TGs in males in the SHS. This result is counterintuitive to the association of lower 2-h glucose, lower fasting insulin, and lower HOMA value. A current issue in genetics is the extension of associated loci discovered using genome-wide association studies (GWAS) in European ancestry to non-European individuals (Murray et al. <xref ref-type="bibr" rid="CR18">2010</xref>; Teslovich et al. <xref ref-type="bibr" rid="CR32">2010</xref>). For example, a recent study (Murray et al. <xref ref-type="bibr" rid="CR18">2010</xref>) examined SNPs for asthma risk in two African ancestry groups that were located near a gene encoding ORMDL3 (17q21) that was identified for asthma risk in individuals with European-descent (Moffatt et al. <xref ref-type="bibr" rid="CR16">2007</xref>). The SNPs near the <italic>ORMDL3</italic> gene did not replicate risk for asthma in the African ancestry groups (Murray et al. <xref ref-type="bibr" rid="CR18">2010</xref>). Concurrently, another study focusing on the genetics of blood lipids found 24 of 27 SNPs replicated for TG values between European-descent and South Asians, a replication of 26 of 28 SNPs for TG values in East Asians, and a replication of 24 of 30 SNPs for TG values in African-Americans (Teslovich et al. <xref ref-type="bibr" rid="CR32">2010</xref>). These results speak of the difficulty that exists in understanding genetic variation and its relationship to different phenotypes in different ethnic groups. The higher TG values associated with H2 haplotype in the SHS may be due an interaction with the lack of access to medications that can control lipids (Stern <xref ref-type="bibr" rid="CR29">1998</xref>) and genotype. Finally, there is an ongoing unfavorable increase in the prevalence of hypertension, low HDL, and diabetes mellitus in the aging survivors of the SHS and this will likely lead to further increases in CVD morbidity and mortality. This interaction between <italic>AKT1</italic> H2 and TG will need to be further explored in additional populations.</p><p>To our knowledge, the 12&#x000a0;kb haplotype described here is one of the strongest candidate gene studies for either insulin resistance or a metabolic syndrome diagnosis identified to date. In another report, we report function for all the SNPs in the associated haplotype (Harmon et al. 2010, submitted). In future studies, we will examine how this AKT1 haplotype impacts the effect on insulin resistance when combined with the numerous reported genome-wide association studies (GWAS) of isolated insulin resistance (Lyssenko et al. <xref ref-type="bibr" rid="CR15">2009</xref>), insulin response (Rich et al. <xref ref-type="bibr" rid="CR22">2009</xref>), fasting glucose (Bouatia-Naji et al. <xref ref-type="bibr" rid="CR6">2008</xref>; Dupuis et al. <xref ref-type="bibr" rid="CR7">2010</xref>; Prokopenko et al. <xref ref-type="bibr" rid="CR20">2009</xref>), glucose response (Saxena et al. <xref ref-type="bibr" rid="CR25">2010</xref>), and GWAS studies of the fully morbid T2D diagnosis (Wellcome Trust Case Control Consortium <xref ref-type="bibr" rid="CR1">2007</xref>; Rung et al. <xref ref-type="bibr" rid="CR23">2009</xref>; Saxena et al. <xref ref-type="bibr" rid="CR24">2007</xref>; Scott et al. <xref ref-type="bibr" rid="CR26">2007</xref>; Zeggini et al. <xref ref-type="bibr" rid="CR39">2008</xref>).</p></sec><sec sec-type="supplementary-material"><sec id="AppESM1"><title>Electronic supplementary material</title><supplementary-material id="d28e2544" content-type="local-data"><p>Below is the link to the electronic supplementary material.

</p><media xlink:href="439_2010_910_MOESM1_ESM.doc" id="MOESM1" mimetype="application" mime-subtype="msword"><caption><p>Supplementary material 1 (DOC 79 kb)</p></caption></media></supplementary-material></sec></sec></body><back><ack><title>Open Access</title><p>This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.</p></ack><ref-list id="Bib1"><title>References</title><ref id="CR2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alberti</surname><given-names>KG</given-names></name><name><surname>Zimmet</surname><given-names>PZ</given-names></name></person-group><article-title>Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation</article-title><source>Diabet Med</source><year>1998</year><volume>15</volume><fpage>539</fpage><lpage>553</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1096-9136(199807)15:7&#x0003c;539::AID-DIA668&#x0003e;3.0.CO;2-S</pub-id><pub-id pub-id-type="pmid">9686693</pub-id></mixed-citation></ref><ref id="CR3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alberti</surname><given-names>KG</given-names></name><name><surname>Zimmet</surname><given-names>P</given-names></name><name><surname>Shaw</surname><given-names>J</given-names></name></person-group><article-title>Metabolic syndrome&#x02014;a new world-wide definition. A consensus statement from the International Diabetes Federation</article-title><source>Diabet Med</source><year>2006</year><volume>23</volume><fpage>469</fpage><lpage>480</lpage><pub-id pub-id-type="doi">10.1111/j.1464-5491.2006.01858.x</pub-id><pub-id pub-id-type="pmid">16681555</pub-id></mixed-citation></ref><ref id="CR4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bernal-Mizrachi</surname><given-names>E</given-names></name><name><surname>Wen</surname><given-names>W</given-names></name><name><surname>Stahlhut</surname><given-names>S</given-names></name><name><surname>Welling</surname><given-names>CM</given-names></name><name><surname>Permutt</surname><given-names>MA</given-names></name></person-group><article-title>Islet beta cell expression of constitutively active Akt1/PKB alpha induces striking hypertrophy, hyperplasia, and hyperinsulinemia</article-title><source>J Clin Investig</source><year>2001</year><volume>108</volume><fpage>1631</fpage><lpage>1638</lpage><pub-id pub-id-type="pmid">11733558</pub-id></mixed-citation></ref><ref id="CR5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bernal-Mizrachi</surname><given-names>E</given-names></name><name><surname>Fatrai</surname><given-names>S</given-names></name><name><surname>Johnson</surname><given-names>JD</given-names></name><name><surname>Ohsugi</surname><given-names>M</given-names></name><name><surname>Otani</surname><given-names>K</given-names></name><name><surname>Han</surname><given-names>Z</given-names></name><name><surname>Polonsky</surname><given-names>KS</given-names></name><name><surname>Permutt</surname><given-names>MA</given-names></name></person-group><article-title>Defective insulin secretion and increased susceptibility to experimental diabetes are induced by reduced Akt activity in pancreatic islet beta cells</article-title><source>J Clin Investig</source><year>2004</year><volume>114</volume><fpage>928</fpage><lpage>936</lpage><pub-id pub-id-type="pmid">15467831</pub-id></mixed-citation></ref><ref id="CR6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bouatia-Naji</surname><given-names>N</given-names></name><name><surname>Rocheleau</surname><given-names>G</given-names></name><name><surname>Lommel</surname><given-names>L</given-names></name><name><surname>Lemaire</surname><given-names>K</given-names></name><name><surname>Schuit</surname><given-names>F</given-names></name><name><surname>Cavalcanti-Proenca</surname><given-names>C</given-names></name><name><surname>Marchand</surname><given-names>M</given-names></name><name><surname>Hartikainen</surname><given-names>AL</given-names></name><name><surname>Sovio</surname><given-names>U</given-names></name><name><surname>Graeve</surname><given-names>F</given-names></name><name><surname>Rung</surname><given-names>J</given-names></name><name><surname>Vaxillaire</surname><given-names>M</given-names></name><name><surname>Tichet</surname><given-names>J</given-names></name><name><surname>Marre</surname><given-names>M</given-names></name><name><surname>Balkau</surname><given-names>B</given-names></name><name><surname>Weill</surname><given-names>J</given-names></name><name><surname>Elliott</surname><given-names>P</given-names></name><name><surname>Jarvelin</surname><given-names>MR</given-names></name><name><surname>Meyre</surname><given-names>D</given-names></name><name><surname>Polychronakos</surname><given-names>C</given-names></name><name><surname>Dina</surname><given-names>C</given-names></name><name><surname>Sladek</surname><given-names>R</given-names></name><name><surname>Froguel</surname><given-names>P</given-names></name></person-group><article-title>A polymorphism within the G6PC2 gene is associated with fasting plasma glucose levels</article-title><source>Science</source><year>2008</year><volume>320</volume><fpage>1085</fpage><lpage>1088</lpage><pub-id pub-id-type="doi">10.1126/science.1156849</pub-id><pub-id pub-id-type="pmid">18451265</pub-id></mixed-citation></ref><ref id="CR7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dupuis</surname><given-names>J</given-names></name><name><surname>Langenberg</surname><given-names>C</given-names></name><name><surname>Prokopenko</surname><given-names>I</given-names></name><name><surname>Saxena</surname><given-names>R</given-names></name><name><surname>Soranzo</surname><given-names>N</given-names></name><name><surname>Jackson</surname><given-names>AU</given-names></name><name><surname>Wheeler</surname><given-names>E</given-names></name><name><surname>Glazer</surname><given-names>NL</given-names></name><name><surname>Bouatia-Naji</surname><given-names>N</given-names></name><name><surname>Gloyn</surname><given-names>AL</given-names></name><name><surname>Lindgren</surname><given-names>CM</given-names></name><name><surname>Magi</surname><given-names>R</given-names></name><name><surname>Morris</surname><given-names>AP</given-names></name><name><surname>Randall</surname><given-names>J</given-names></name><name><surname>Johnson</surname><given-names>T</given-names></name><name><surname>Elliott</surname><given-names>P</given-names></name><name><surname>Rybin</surname><given-names>D</given-names></name><name><surname>Thorleifsson</surname><given-names>G</given-names></name><name><surname>Steinthorsdottir</surname><given-names>V</given-names></name><name><surname>Henneman</surname><given-names>P</given-names></name><name><surname>Grallert</surname><given-names>H</given-names></name><name><surname>Dehghan</surname><given-names>A</given-names></name><name><surname>Hottenga</surname><given-names>JJ</given-names></name><name><surname>Franklin</surname><given-names>CS</given-names></name><name><surname>Navarro</surname><given-names>P</given-names></name><name><surname>Song</surname><given-names>K</given-names></name><name><surname>Goel</surname><given-names>A</given-names></name><name><surname>Perry</surname><given-names>JR</given-names></name><name><surname>Egan</surname><given-names>JM</given-names></name><name><surname>Lajunen</surname><given-names>T</given-names></name><name><surname>Grarup</surname><given-names>N</given-names></name><name><surname>Sparso</surname><given-names>T</given-names></name><name><surname>Doney</surname><given-names>A</given-names></name><name><surname>Voight</surname><given-names>BF</given-names></name><name><surname>Stringham</surname><given-names>HM</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Kanoni</surname><given-names>S</given-names></name><name><surname>Shrader</surname><given-names>P</given-names></name><name><surname>Cavalcanti-Proenca</surname><given-names>C</given-names></name><name><surname>Kumari</surname><given-names>M</given-names></name><name><surname>Qi</surname><given-names>L</given-names></name><name><surname>Timpson</surname><given-names>NJ</given-names></name><name><surname>Gieger</surname><given-names>C</given-names></name><name><surname>Zabena</surname><given-names>C</given-names></name><name><surname>Rocheleau</surname><given-names>G</given-names></name><name><surname>Ingelsson</surname><given-names>E</given-names></name><name><surname>An</surname><given-names>P</given-names></name><name><surname>O&#x02019;Connell</surname><given-names>J</given-names></name><name><surname>Luan</surname><given-names>J</given-names></name><name><surname>Elliott</surname><given-names>A</given-names></name><name><surname>McCarroll</surname><given-names>SA</given-names></name><name><surname>Payne</surname><given-names>F</given-names></name><name><surname>Roccasecca</surname><given-names>RM</given-names></name><name><surname>Pattou</surname><given-names>F</given-names></name><name><surname>Sethupathy</surname><given-names>P</given-names></name><name><surname>Ardlie</surname><given-names>K</given-names></name><name><surname>Ariyurek</surname><given-names>Y</given-names></name><name><surname>Balkau</surname><given-names>B</given-names></name><name><surname>Barter</surname><given-names>P</given-names></name><name><surname>Beilby</surname><given-names>JP</given-names></name><name><surname>Ben-Shlomo</surname><given-names>Y</given-names></name><name><surname>Benediktsson</surname><given-names>R</given-names></name><name><surname>Bennett</surname><given-names>AJ</given-names></name><name><surname>Bergmann</surname><given-names>S</given-names></name><name><surname>Bochud</surname><given-names>M</given-names></name><name><surname>Boerwinkle</surname><given-names>E</given-names></name><name><surname>Bonnefond</surname><given-names>A</given-names></name><name><surname>Bonnycastle</surname><given-names>LL</given-names></name><name><surname>Borch-Johnsen</surname><given-names>K</given-names></name><name><surname>Bottcher</surname><given-names>Y</given-names></name><name><surname>Brunner</surname><given-names>E</given-names></name><name><surname>Bumpstead</surname><given-names>SJ</given-names></name><name><surname>Charpentier</surname><given-names>G</given-names></name><name><surname>Chen</surname><given-names>YD</given-names></name><name><surname>Chines</surname><given-names>P</given-names></name><name><surname>Clarke</surname><given-names>R</given-names></name><name><surname>Coin</surname><given-names>LJ</given-names></name><name><surname>Cooper</surname><given-names>MN</given-names></name><name><surname>Cornelis</surname><given-names>M</given-names></name><name><surname>Crawford</surname><given-names>G</given-names></name><name><surname>Crisponi</surname><given-names>L</given-names></name><name><surname>Day</surname><given-names>IN</given-names></name><name><surname>Geus</surname><given-names>EJ</given-names></name><name><surname>Delplanque</surname><given-names>J</given-names></name><name><surname>Dina</surname><given-names>C</given-names></name><name><surname>Erdos</surname><given-names>MR</given-names></name><name><surname>Fedson</surname><given-names>AC</given-names></name><name><surname>Fischer-Rosinsky</surname><given-names>A</given-names></name><name><surname>Forouhi</surname><given-names>NG</given-names></name><name><surname>Fox</surname><given-names>CS</given-names></name><name><surname>Frants</surname><given-names>R</given-names></name><name><surname>Franzosi</surname><given-names>MG</given-names></name><name><surname>Galan</surname><given-names>P</given-names></name><name><surname>Goodarzi</surname><given-names>MO</given-names></name><name><surname>Graessler</surname><given-names>J</given-names></name><name><surname>Groves</surname><given-names>CJ</given-names></name><name><surname>Grundy</surname><given-names>S</given-names></name><name><surname>Gwilliam</surname><given-names>R</given-names></name><name><surname>Gyllensten</surname><given-names>U</given-names></name><name><surname>Hadjadj</surname><given-names>S</given-names></name><etal/></person-group><article-title>New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk</article-title><source>Nat Genet</source><year>2010</year><volume>42</volume><fpage>105</fpage><lpage>116</lpage><pub-id pub-id-type="doi">10.1038/ng.520</pub-id><pub-id pub-id-type="pmid">20081858</pub-id></mixed-citation></ref><ref id="CR8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elghazi</surname><given-names>L</given-names></name><name><surname>Balcazar</surname><given-names>N</given-names></name><name><surname>Bernal-Mizrachi</surname><given-names>E</given-names></name></person-group><article-title>Emerging role of protein kinase B/Akt signaling in pancreatic beta-cell mass and function</article-title><source>Int J Biochem Cell Biol</source><year>2006</year><volume>38</volume><fpage>157</fpage><lpage>163</lpage><pub-id pub-id-type="doi">10.1016/j.biocel.2006.01.005</pub-id><pub-id pub-id-type="pmid">16213777</pub-id></mixed-citation></ref><ref id="CR9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frevert</surname><given-names>EU</given-names></name><name><surname>Bjorbaek</surname><given-names>C</given-names></name><name><surname>Venable</surname><given-names>CL</given-names></name><name><surname>Keller</surname><given-names>SR</given-names></name><name><surname>Kahn</surname><given-names>BB</given-names></name></person-group><article-title>Targeting of constitutively active phosphoinositide 3-kinase to GLUT4-containing vesicles in 3T3&#x02013;L1 adipocytes</article-title><source>J Biol Chem</source><year>1998</year><volume>273</volume><fpage>25480</fpage><lpage>25487</lpage><pub-id pub-id-type="doi">10.1074/jbc.273.39.25480</pub-id><pub-id pub-id-type="pmid">9738018</pub-id></mixed-citation></ref><ref id="CR10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grundy</surname><given-names>SM</given-names></name><name><surname>Brewer</surname><given-names>HB</given-names><suffix>Jr</suffix></name><name><surname>Cleeman</surname><given-names>JI</given-names></name><name><surname>Smith</surname><given-names>SC</given-names><suffix>Jr</suffix></name><name><surname>Lenfant</surname><given-names>C</given-names></name></person-group><article-title>Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition</article-title><source>Circulation</source><year>2004</year><volume>109</volume><fpage>433</fpage><lpage>438</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.0000111245.75752.C6</pub-id><pub-id pub-id-type="pmid">14744958</pub-id></mixed-citation></ref><ref id="CR11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hajduch</surname><given-names>E</given-names></name><name><surname>Alessi</surname><given-names>DR</given-names></name><name><surname>Hemmings</surname><given-names>BA</given-names></name><name><surname>Hundal</surname><given-names>HS</given-names></name></person-group><article-title>Constitutive activation of protein kinase B alpha by membrane targeting promotes glucose and system A amino acid transport, protein synthesis, and inactivation of glycogen synthase kinase 3 in L6 muscle cells</article-title><source>Diabetes</source><year>1998</year><volume>47</volume><fpage>1006</fpage><lpage>1013</lpage><pub-id pub-id-type="doi">10.2337/diabetes.47.7.1006</pub-id><pub-id pub-id-type="pmid">9648821</pub-id></mixed-citation></ref><ref id="CR12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harris</surname><given-names>SL</given-names></name><name><surname>Gil</surname><given-names>G</given-names></name><name><surname>Robins</surname><given-names>H</given-names></name><name><surname>Hu</surname><given-names>W</given-names></name><name><surname>Hirshfield</surname><given-names>K</given-names></name><name><surname>Bond</surname><given-names>E</given-names></name><name><surname>Bond</surname><given-names>G</given-names></name><name><surname>Levine</surname><given-names>AJ</given-names></name></person-group><article-title>Detection of functional single-nucleotide polymorphisms that affect apoptosis</article-title><source>Proc Natl Acad Sci USA</source><year>2005</year><volume>102</volume><fpage>16297</fpage><lpage>16302</lpage><pub-id pub-id-type="doi">10.1073/pnas.0508390102</pub-id><pub-id pub-id-type="pmid">16260726</pub-id></mixed-citation></ref><ref id="CR13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>AC</given-names></name><name><surname>Austin</surname><given-names>J</given-names></name><name><surname>Hansen</surname><given-names>N</given-names></name><name><surname>Hoogendoorn</surname><given-names>B</given-names></name><name><surname>Oefner</surname><given-names>PJ</given-names></name><name><surname>Cheadle</surname><given-names>JP</given-names></name><name><surname>O&#x02019;Donovan</surname><given-names>MC</given-names></name></person-group><article-title>Optimal temperature selection for mutation detection by denaturing HPLC and comparison to single-stranded conformation polymorphism and heteroduplex analysis</article-title><source>Clin Chem</source><year>1999</year><volume>45</volume><fpage>1133</fpage><lpage>1140</lpage><pub-id pub-id-type="pmid">10430776</pub-id></mixed-citation></ref><ref id="CR14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>ET</given-names></name><name><surname>Welty</surname><given-names>TK</given-names></name><name><surname>Fabsitz</surname><given-names>R</given-names></name><name><surname>Cowan</surname><given-names>LD</given-names></name><name><surname>Le</surname><given-names>NA</given-names></name><name><surname>Oopik</surname><given-names>AJ</given-names></name><name><surname>Cucchiara</surname><given-names>AJ</given-names></name><name><surname>Savage</surname><given-names>PJ</given-names></name><name><surname>Howard</surname><given-names>BV</given-names></name></person-group><article-title>The Strong Heart Study. A study of cardiovascular disease in American Indians: design and methods</article-title><source>Am J Epidemiol</source><year>1990</year><volume>132</volume><fpage>1141</fpage><lpage>1155</lpage><pub-id pub-id-type="pmid">2260546</pub-id></mixed-citation></ref><ref id="CR15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lyssenko</surname><given-names>V</given-names></name><name><surname>Nagorny</surname><given-names>CL</given-names></name><name><surname>Erdos</surname><given-names>MR</given-names></name><name><surname>Wierup</surname><given-names>N</given-names></name><name><surname>Jonsson</surname><given-names>A</given-names></name><name><surname>Spegel</surname><given-names>P</given-names></name><name><surname>Bugliani</surname><given-names>M</given-names></name><name><surname>Saxena</surname><given-names>R</given-names></name><name><surname>Fex</surname><given-names>M</given-names></name><name><surname>Pulizzi</surname><given-names>N</given-names></name><name><surname>Isomaa</surname><given-names>B</given-names></name><name><surname>Tuomi</surname><given-names>T</given-names></name><name><surname>Nilsson</surname><given-names>P</given-names></name><name><surname>Kuusisto</surname><given-names>J</given-names></name><name><surname>Tuomilehto</surname><given-names>J</given-names></name><name><surname>Boehnke</surname><given-names>M</given-names></name><name><surname>Altshuler</surname><given-names>D</given-names></name><name><surname>Sundler</surname><given-names>F</given-names></name><name><surname>Eriksson</surname><given-names>JG</given-names></name><name><surname>Jackson</surname><given-names>AU</given-names></name><name><surname>Laakso</surname><given-names>M</given-names></name><name><surname>Marchetti</surname><given-names>P</given-names></name><name><surname>Watanabe</surname><given-names>RM</given-names></name><name><surname>Mulder</surname><given-names>H</given-names></name><name><surname>Groop</surname><given-names>L</given-names></name></person-group><article-title>Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion</article-title><source>Nat Genet</source><year>2009</year><volume>41</volume><fpage>82</fpage><lpage>88</lpage><pub-id pub-id-type="doi">10.1038/ng.288</pub-id><pub-id pub-id-type="pmid">19060908</pub-id></mixed-citation></ref><ref id="CR16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moffatt</surname><given-names>MF</given-names></name><name><surname>Kabesch</surname><given-names>M</given-names></name><name><surname>Liang</surname><given-names>L</given-names></name><name><surname>Dixon</surname><given-names>AL</given-names></name><name><surname>Strachan</surname><given-names>D</given-names></name><name><surname>Heath</surname><given-names>S</given-names></name><name><surname>Depner</surname><given-names>M</given-names></name><name><surname>Berg</surname><given-names>A</given-names></name><name><surname>Bufe</surname><given-names>A</given-names></name><name><surname>Rietschel</surname><given-names>E</given-names></name><name><surname>Heinzmann</surname><given-names>A</given-names></name><name><surname>Simma</surname><given-names>B</given-names></name><name><surname>Frischer</surname><given-names>T</given-names></name><name><surname>Willis-Owen</surname><given-names>SA</given-names></name><name><surname>Wong</surname><given-names>KC</given-names></name><name><surname>Illig</surname><given-names>T</given-names></name><name><surname>Vogelberg</surname><given-names>C</given-names></name><name><surname>Weiland</surname><given-names>SK</given-names></name><name><surname>Mutius</surname><given-names>E</given-names></name><name><surname>Abecasis</surname><given-names>GR</given-names></name><name><surname>Farrall</surname><given-names>M</given-names></name><name><surname>Gut</surname><given-names>IG</given-names></name><name><surname>Lathrop</surname><given-names>GM</given-names></name><name><surname>Cookson</surname><given-names>WO</given-names></name></person-group><article-title>Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma</article-title><source>Nature</source><year>2007</year><volume>448</volume><fpage>470</fpage><lpage>473</lpage><pub-id pub-id-type="doi">10.1038/nature06014</pub-id><pub-id pub-id-type="pmid">17611496</pub-id></mixed-citation></ref><ref id="CR17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mogensen</surname><given-names>J</given-names></name><name><surname>Bahl</surname><given-names>A</given-names></name><name><surname>Kubo</surname><given-names>T</given-names></name><name><surname>Elanko</surname><given-names>N</given-names></name><name><surname>Taylor</surname><given-names>R</given-names></name><name><surname>McKenna</surname><given-names>WJ</given-names></name></person-group><article-title>Comparison of fluorescent SSCP and denaturing HPLC analysis with direct sequencing for mutation screening in hypertrophic cardiomyopathy</article-title><source>J Med Genet</source><year>2003</year><volume>40</volume><fpage>e59</fpage><pub-id pub-id-type="doi">10.1136/jmg.40.5.e59</pub-id><pub-id pub-id-type="pmid">12746413</pub-id></mixed-citation></ref><ref id="CR18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murray</surname><given-names>T</given-names></name><name><surname>Beaty</surname><given-names>TH</given-names></name><name><surname>Mathias</surname><given-names>RA</given-names></name><name><surname>Rafaels</surname><given-names>N</given-names></name><name><surname>Grant</surname><given-names>AV</given-names></name><name><surname>Faruque</surname><given-names>MU</given-names></name><name><surname>Watson</surname><given-names>HR</given-names></name><name><surname>Ruczinski</surname><given-names>I</given-names></name><name><surname>Dunston</surname><given-names>GM</given-names></name><name><surname>Barnes</surname><given-names>KC</given-names></name></person-group><article-title>African and non-African admixture components in African Americans and an African Caribbean population</article-title><source>Genet Epidemiol</source><year>2010</year><volume>34</volume><issue>6</issue><fpage>561</fpage><lpage>568</lpage><pub-id pub-id-type="doi">10.1002/gepi.20512</pub-id><pub-id pub-id-type="pmid">20717976</pub-id></mixed-citation></ref><ref id="CR19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nader</surname><given-names>GA</given-names></name></person-group><article-title>Molecular determinants of skeletal muscle mass: getting the &#x0201c;AKT&#x0201d; together</article-title><source>Int J Biochem Cell Biol</source><year>2005</year><volume>37</volume><fpage>1985</fpage><lpage>1996</lpage><pub-id pub-id-type="doi">10.1016/j.biocel.2005.02.026</pub-id><pub-id pub-id-type="pmid">16125108</pub-id></mixed-citation></ref><ref id="CR37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><collab>NCEP</collab></person-group><article-title>Executive summary of the third report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)</article-title><source>JAMA</source><year>2001</year><volume>285</volume><fpage>2486</fpage><lpage>2497</lpage><pub-id pub-id-type="doi">10.1001/jama.285.19.2486</pub-id><pub-id pub-id-type="pmid">11368702</pub-id></mixed-citation></ref><ref id="CR20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prokopenko</surname><given-names>I</given-names></name><name><surname>Langenberg</surname><given-names>C</given-names></name><name><surname>Florez</surname><given-names>JC</given-names></name><name><surname>Saxena</surname><given-names>R</given-names></name><name><surname>Soranzo</surname><given-names>N</given-names></name><name><surname>Thorleifsson</surname><given-names>G</given-names></name><name><surname>Loos</surname><given-names>RJ</given-names></name><name><surname>Manning</surname><given-names>AK</given-names></name><name><surname>Jackson</surname><given-names>AU</given-names></name><name><surname>Aulchenko</surname><given-names>Y</given-names></name><name><surname>Potter</surname><given-names>SC</given-names></name><name><surname>Erdos</surname><given-names>MR</given-names></name><name><surname>Sanna</surname><given-names>S</given-names></name><name><surname>Hottenga</surname><given-names>JJ</given-names></name><name><surname>Wheeler</surname><given-names>E</given-names></name><name><surname>Kaakinen</surname><given-names>M</given-names></name><name><surname>Lyssenko</surname><given-names>V</given-names></name><name><surname>Chen</surname><given-names>WM</given-names></name><name><surname>Ahmadi</surname><given-names>K</given-names></name><name><surname>Beckmann</surname><given-names>JS</given-names></name><name><surname>Bergman</surname><given-names>RN</given-names></name><name><surname>Bochud</surname><given-names>M</given-names></name><name><surname>Bonnycastle</surname><given-names>LL</given-names></name><name><surname>Buchanan</surname><given-names>TA</given-names></name><name><surname>Cao</surname><given-names>A</given-names></name><name><surname>Cervino</surname><given-names>A</given-names></name><name><surname>Coin</surname><given-names>L</given-names></name><name><surname>Collins</surname><given-names>FS</given-names></name><name><surname>Crisponi</surname><given-names>L</given-names></name><name><surname>Geus</surname><given-names>EJ</given-names></name><name><surname>Dehghan</surname><given-names>A</given-names></name><name><surname>Deloukas</surname><given-names>P</given-names></name><name><surname>Doney</surname><given-names>AS</given-names></name><name><surname>Elliott</surname><given-names>P</given-names></name><name><surname>Freimer</surname><given-names>N</given-names></name><name><surname>Gateva</surname><given-names>V</given-names></name><name><surname>Herder</surname><given-names>C</given-names></name><name><surname>Hofman</surname><given-names>A</given-names></name><name><surname>Hughes</surname><given-names>TE</given-names></name><name><surname>Hunt</surname><given-names>S</given-names></name><name><surname>Illig</surname><given-names>T</given-names></name><name><surname>Inouye</surname><given-names>M</given-names></name><name><surname>Isomaa</surname><given-names>B</given-names></name><name><surname>Johnson</surname><given-names>T</given-names></name><name><surname>Kong</surname><given-names>A</given-names></name><name><surname>Krestyaninova</surname><given-names>M</given-names></name><name><surname>Kuusisto</surname><given-names>J</given-names></name><name><surname>Laakso</surname><given-names>M</given-names></name><name><surname>Lim</surname><given-names>N</given-names></name><name><surname>Lindblad</surname><given-names>U</given-names></name><name><surname>Lindgren</surname><given-names>CM</given-names></name><name><surname>McCann</surname><given-names>OT</given-names></name><name><surname>Mohlke</surname><given-names>KL</given-names></name><name><surname>Morris</surname><given-names>AD</given-names></name><name><surname>Naitza</surname><given-names>S</given-names></name><name><surname>Orru</surname><given-names>M</given-names></name><name><surname>Palmer</surname><given-names>CN</given-names></name><name><surname>Pouta</surname><given-names>A</given-names></name><name><surname>Randall</surname><given-names>J</given-names></name><name><surname>Rathmann</surname><given-names>W</given-names></name><name><surname>Saramies</surname><given-names>J</given-names></name><name><surname>Scheet</surname><given-names>P</given-names></name><name><surname>Scott</surname><given-names>LJ</given-names></name><name><surname>Scuteri</surname><given-names>A</given-names></name><name><surname>Sharp</surname><given-names>S</given-names></name><name><surname>Sijbrands</surname><given-names>E</given-names></name><name><surname>Smit</surname><given-names>JH</given-names></name><name><surname>Song</surname><given-names>K</given-names></name><name><surname>Steinthorsdottir</surname><given-names>V</given-names></name><name><surname>Stringham</surname><given-names>HM</given-names></name><name><surname>Tuomi</surname><given-names>T</given-names></name><name><surname>Tuomilehto</surname><given-names>J</given-names></name><name><surname>Uitterlinden</surname><given-names>AG</given-names></name><name><surname>Voight</surname><given-names>BF</given-names></name><name><surname>Waterworth</surname><given-names>D</given-names></name><name><surname>Wichmann</surname><given-names>HE</given-names></name><name><surname>Willemsen</surname><given-names>G</given-names></name><name><surname>Witteman</surname><given-names>JC</given-names></name><name><surname>Yuan</surname><given-names>X</given-names></name><name><surname>Zhao</surname><given-names>JH</given-names></name><name><surname>Zeggini</surname><given-names>E</given-names></name><name><surname>Schlessinger</surname><given-names>D</given-names></name><name><surname>Sandhu</surname><given-names>M</given-names></name><name><surname>Boomsma</surname><given-names>DI</given-names></name><name><surname>Uda</surname><given-names>M</given-names></name><name><surname>Spector</surname><given-names>TD</given-names></name><name><surname>Penninx</surname><given-names>BW</given-names></name><name><surname>Altshuler</surname><given-names>D</given-names></name><name><surname>Vollenweider</surname><given-names>P</given-names></name><name><surname>Jarvelin</surname><given-names>MR</given-names></name><name><surname>Lakatta</surname><given-names>E</given-names></name><name><surname>Waeber</surname><given-names>G</given-names></name><name><surname>Fox</surname><given-names>CS</given-names></name><name><surname>Peltonen</surname><given-names>L</given-names></name><name><surname>Groop</surname><given-names>LC</given-names></name><name><surname>Mooser</surname><given-names>V</given-names></name><name><surname>Cupples</surname><given-names>LA</given-names></name><name><surname>Thorsteinsdottir</surname><given-names>U</given-names></name><name><surname>Boehnke</surname><given-names>M</given-names></name><name><surname>Barroso</surname><given-names>I</given-names></name><etal/></person-group><article-title>Variants in MTNR1B influence fasting glucose levels</article-title><source>Nat Genet</source><year>2009</year><volume>41</volume><fpage>77</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1038/ng.290</pub-id><pub-id pub-id-type="pmid">19060907</pub-id></mixed-citation></ref><ref id="CR21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rice</surname><given-names>TK</given-names></name><name><surname>Schork</surname><given-names>NJ</given-names></name><name><surname>Rao</surname><given-names>DC</given-names></name></person-group><article-title>Methods for handling multiple testing</article-title><source>Adv Genet</source><year>2008</year><volume>60</volume><fpage>293</fpage><lpage>308</lpage><pub-id pub-id-type="doi">10.1016/S0065-2660(07)00412-9</pub-id><pub-id pub-id-type="pmid">18358325</pub-id></mixed-citation></ref><ref id="CR22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rich</surname><given-names>SS</given-names></name><name><surname>Goodarzi</surname><given-names>MO</given-names></name><name><surname>Palmer</surname><given-names>ND</given-names></name><name><surname>Langefeld</surname><given-names>CD</given-names></name><name><surname>Ziegler</surname><given-names>J</given-names></name><name><surname>Haffner</surname><given-names>SM</given-names></name><name><surname>Bryer-Ash</surname><given-names>M</given-names></name><name><surname>Norris</surname><given-names>JM</given-names></name><name><surname>Taylor</surname><given-names>KD</given-names></name><name><surname>Haritunians</surname><given-names>T</given-names></name><name><surname>Rotter</surname><given-names>JI</given-names></name><name><surname>Chen</surname><given-names>YD</given-names></name><name><surname>Wagenknecht</surname><given-names>LE</given-names></name><name><surname>Bowden</surname><given-names>DW</given-names></name><name><surname>Bergman</surname><given-names>RN</given-names></name></person-group><article-title>A genome-wide association scan for acute insulin response to glucose in Hispanic-Americans: the Insulin Resistance Atherosclerosis Family Study (IRAS FS)</article-title><source>Diabetologia</source><year>2009</year><volume>52</volume><fpage>1326</fpage><lpage>1333</lpage><pub-id pub-id-type="doi">10.1007/s00125-009-1373-0</pub-id><pub-id pub-id-type="pmid">19430760</pub-id></mixed-citation></ref><ref id="CR23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rung</surname><given-names>J</given-names></name><name><surname>Cauchi</surname><given-names>S</given-names></name><name><surname>Albrechtsen</surname><given-names>A</given-names></name><name><surname>Shen</surname><given-names>L</given-names></name><name><surname>Rocheleau</surname><given-names>G</given-names></name><name><surname>Cavalcanti-Proenca</surname><given-names>C</given-names></name><name><surname>Bacot</surname><given-names>F</given-names></name><name><surname>Balkau</surname><given-names>B</given-names></name><name><surname>Belisle</surname><given-names>A</given-names></name><name><surname>Borch-Johnsen</surname><given-names>K</given-names></name><name><surname>Charpentier</surname><given-names>G</given-names></name><name><surname>Dina</surname><given-names>C</given-names></name><name><surname>Durand</surname><given-names>E</given-names></name><name><surname>Elliott</surname><given-names>P</given-names></name><name><surname>Hadjadj</surname><given-names>S</given-names></name><name><surname>Jarvelin</surname><given-names>MR</given-names></name><name><surname>Laitinen</surname><given-names>J</given-names></name><name><surname>Lauritzen</surname><given-names>T</given-names></name><name><surname>Marre</surname><given-names>M</given-names></name><name><surname>Mazur</surname><given-names>A</given-names></name><name><surname>Meyre</surname><given-names>D</given-names></name><name><surname>Montpetit</surname><given-names>A</given-names></name><name><surname>Pisinger</surname><given-names>C</given-names></name><name><surname>Posner</surname><given-names>B</given-names></name><name><surname>Poulsen</surname><given-names>P</given-names></name><name><surname>Pouta</surname><given-names>A</given-names></name><name><surname>Prentki</surname><given-names>M</given-names></name><name><surname>Ribel-Madsen</surname><given-names>R</given-names></name><name><surname>Ruokonen</surname><given-names>A</given-names></name><name><surname>Sandbaek</surname><given-names>A</given-names></name><name><surname>Serre</surname><given-names>D</given-names></name><name><surname>Tichet</surname><given-names>J</given-names></name><name><surname>Vaxillaire</surname><given-names>M</given-names></name><name><surname>Wojtaszewski</surname><given-names>JF</given-names></name><name><surname>Vaag</surname><given-names>A</given-names></name><name><surname>Hansen</surname><given-names>T</given-names></name><name><surname>Polychronakos</surname><given-names>C</given-names></name><name><surname>Pedersen</surname><given-names>O</given-names></name><name><surname>Froguel</surname><given-names>P</given-names></name><name><surname>Sladek</surname><given-names>R</given-names></name></person-group><article-title>Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia</article-title><source>Nat Genet</source><year>2009</year><volume>41</volume><fpage>1110</fpage><lpage>1115</lpage><pub-id pub-id-type="doi">10.1038/ng.443</pub-id><pub-id pub-id-type="pmid">19734900</pub-id></mixed-citation></ref><ref id="CR24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saxena</surname><given-names>R</given-names></name><name><surname>Voight</surname><given-names>BF</given-names></name><name><surname>Lyssenko</surname><given-names>V</given-names></name><name><surname>Burtt</surname><given-names>NP</given-names></name><name><surname>Bakker</surname><given-names>PI</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Roix</surname><given-names>JJ</given-names></name><name><surname>Kathiresan</surname><given-names>S</given-names></name><name><surname>Hirschhorn</surname><given-names>JN</given-names></name><name><surname>Daly</surname><given-names>MJ</given-names></name><name><surname>Hughes</surname><given-names>TE</given-names></name><name><surname>Groop</surname><given-names>L</given-names></name><name><surname>Altshuler</surname><given-names>D</given-names></name><name><surname>Almgren</surname><given-names>P</given-names></name><name><surname>Florez</surname><given-names>JC</given-names></name><name><surname>Meyer</surname><given-names>J</given-names></name><name><surname>Ardlie</surname><given-names>K</given-names></name><name><surname>Bengtsson Bostrom</surname><given-names>K</given-names></name><name><surname>Isomaa</surname><given-names>B</given-names></name><name><surname>Lettre</surname><given-names>G</given-names></name><name><surname>Lindblad</surname><given-names>U</given-names></name><name><surname>Lyon</surname><given-names>HN</given-names></name><name><surname>Melander</surname><given-names>O</given-names></name><name><surname>Newton-Cheh</surname><given-names>C</given-names></name><name><surname>Nilsson</surname><given-names>P</given-names></name><name><surname>Orho-Melander</surname><given-names>M</given-names></name><name><surname>Rastam</surname><given-names>L</given-names></name><name><surname>Speliotes</surname><given-names>EK</given-names></name><name><surname>Taskinen</surname><given-names>MR</given-names></name><name><surname>Tuomi</surname><given-names>T</given-names></name><name><surname>Guiducci</surname><given-names>C</given-names></name><name><surname>Berglund</surname><given-names>A</given-names></name><name><surname>Carlson</surname><given-names>J</given-names></name><name><surname>Gianniny</surname><given-names>L</given-names></name><name><surname>Hackett</surname><given-names>R</given-names></name><name><surname>Hall</surname><given-names>L</given-names></name><name><surname>Holmkvist</surname><given-names>J</given-names></name><name><surname>Laurila</surname><given-names>E</given-names></name><name><surname>Sjogren</surname><given-names>M</given-names></name><name><surname>Sterner</surname><given-names>M</given-names></name><name><surname>Surti</surname><given-names>A</given-names></name><name><surname>Svensson</surname><given-names>M</given-names></name><name><surname>Tewhey</surname><given-names>R</given-names></name><name><surname>Blumenstiel</surname><given-names>B</given-names></name><name><surname>Parkin</surname><given-names>M</given-names></name><name><surname>Defelice</surname><given-names>M</given-names></name><name><surname>Barry</surname><given-names>R</given-names></name><name><surname>Brodeur</surname><given-names>W</given-names></name><name><surname>Camarata</surname><given-names>J</given-names></name><name><surname>Chia</surname><given-names>N</given-names></name><name><surname>Fava</surname><given-names>M</given-names></name><name><surname>Gibbons</surname><given-names>J</given-names></name><name><surname>Handsaker</surname><given-names>B</given-names></name><name><surname>Healy</surname><given-names>C</given-names></name><name><surname>Nguyen</surname><given-names>K</given-names></name><name><surname>Gates</surname><given-names>C</given-names></name><name><surname>Sougnez</surname><given-names>C</given-names></name><name><surname>Gage</surname><given-names>D</given-names></name><name><surname>Nizzari</surname><given-names>M</given-names></name><name><surname>Gabriel</surname><given-names>SB</given-names></name><name><surname>Chirn</surname><given-names>GW</given-names></name><name><surname>Ma</surname><given-names>Q</given-names></name><name><surname>Parikh</surname><given-names>H</given-names></name><name><surname>Richardson</surname><given-names>D</given-names></name><name><surname>Ricke</surname><given-names>D</given-names></name><name><surname>Purcell</surname><given-names>S</given-names></name></person-group><article-title>Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels</article-title><source>Science</source><year>2007</year><volume>316</volume><fpage>1331</fpage><lpage>1336</lpage><pub-id pub-id-type="doi">10.1126/science.1142358</pub-id><pub-id pub-id-type="pmid">17463246</pub-id></mixed-citation></ref><ref id="CR25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saxena</surname><given-names>R</given-names></name><name><surname>Hivert</surname><given-names>MF</given-names></name><name><surname>Langenberg</surname><given-names>C</given-names></name><name><surname>Tanaka</surname><given-names>T</given-names></name><name><surname>Pankow</surname><given-names>JS</given-names></name><name><surname>Vollenweider</surname><given-names>P</given-names></name><name><surname>Lyssenko</surname><given-names>V</given-names></name><name><surname>Bouatia-Naji</surname><given-names>N</given-names></name><name><surname>Dupuis</surname><given-names>J</given-names></name><name><surname>Jackson</surname><given-names>AU</given-names></name><name><surname>Kao</surname><given-names>WH</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Glazer</surname><given-names>NL</given-names></name><name><surname>Manning</surname><given-names>AK</given-names></name><name><surname>Luan</surname><given-names>J</given-names></name><name><surname>Stringham</surname><given-names>HM</given-names></name><name><surname>Prokopenko</surname><given-names>I</given-names></name><name><surname>Johnson</surname><given-names>T</given-names></name><name><surname>Grarup</surname><given-names>N</given-names></name><name><surname>Boesgaard</surname><given-names>TW</given-names></name><name><surname>Lecoeur</surname><given-names>C</given-names></name><name><surname>Shrader</surname><given-names>P</given-names></name><name><surname>O&#x02019;Connell</surname><given-names>J</given-names></name><name><surname>Ingelsson</surname><given-names>E</given-names></name><name><surname>Couper</surname><given-names>DJ</given-names></name><name><surname>Rice</surname><given-names>K</given-names></name><name><surname>Song</surname><given-names>K</given-names></name><name><surname>Andreasen</surname><given-names>CH</given-names></name><name><surname>Dina</surname><given-names>C</given-names></name><name><surname>Kottgen</surname><given-names>A</given-names></name><name><surname>Le Bacquer</surname><given-names>O</given-names></name><name><surname>Pattou</surname><given-names>F</given-names></name><name><surname>Taneera</surname><given-names>J</given-names></name><name><surname>Steinthorsdottir</surname><given-names>V</given-names></name><name><surname>Rybin</surname><given-names>D</given-names></name><name><surname>Ardlie</surname><given-names>K</given-names></name><name><surname>Sampson</surname><given-names>M</given-names></name><name><surname>Qi</surname><given-names>L</given-names></name><name><surname>Hoek</surname><given-names>M</given-names></name><name><surname>Weedon</surname><given-names>MN</given-names></name><name><surname>Aulchenko</surname><given-names>YS</given-names></name><name><surname>Voight</surname><given-names>BF</given-names></name><name><surname>Grallert</surname><given-names>H</given-names></name><name><surname>Balkau</surname><given-names>B</given-names></name><name><surname>Bergman</surname><given-names>RN</given-names></name><name><surname>Bielinski</surname><given-names>SJ</given-names></name><name><surname>Bonnefond</surname><given-names>A</given-names></name><name><surname>Bonnycastle</surname><given-names>LL</given-names></name><name><surname>Borch-Johnsen</surname><given-names>K</given-names></name><name><surname>Bottcher</surname><given-names>Y</given-names></name><name><surname>Brunner</surname><given-names>E</given-names></name><name><surname>Buchanan</surname><given-names>TA</given-names></name><name><surname>Bumpstead</surname><given-names>SJ</given-names></name><name><surname>Cavalcanti-Proenca</surname><given-names>C</given-names></name><name><surname>Charpentier</surname><given-names>G</given-names></name><name><surname>Chen</surname><given-names>YD</given-names></name><name><surname>Chines</surname><given-names>PS</given-names></name><name><surname>Collins</surname><given-names>FS</given-names></name><name><surname>Cornelis</surname><given-names>M</given-names></name><name><surname>JC</surname><given-names>G</given-names></name><name><surname>Delplanque</surname><given-names>J</given-names></name><name><surname>Doney</surname><given-names>A</given-names></name><name><surname>Egan</surname><given-names>JM</given-names></name><name><surname>Erdos</surname><given-names>MR</given-names></name><name><surname>Firmann</surname><given-names>M</given-names></name><name><surname>Forouhi</surname><given-names>NG</given-names></name><name><surname>Fox</surname><given-names>CS</given-names></name><name><surname>Goodarzi</surname><given-names>MO</given-names></name><name><surname>Graessler</surname><given-names>J</given-names></name><name><surname>Hingorani</surname><given-names>A</given-names></name><name><surname>Isomaa</surname><given-names>B</given-names></name><name><surname>Jorgensen</surname><given-names>T</given-names></name><name><surname>Kivimaki</surname><given-names>M</given-names></name><name><surname>Kovacs</surname><given-names>P</given-names></name><name><surname>Krohn</surname><given-names>K</given-names></name><name><surname>Kumari</surname><given-names>M</given-names></name><name><surname>Lauritzen</surname><given-names>T</given-names></name><name><surname>Levy-Marchal</surname><given-names>C</given-names></name><name><surname>Mayor</surname><given-names>V</given-names></name><name><surname>McAteer</surname><given-names>JB</given-names></name><name><surname>Meyre</surname><given-names>D</given-names></name><name><surname>Mitchell</surname><given-names>BD</given-names></name><name><surname>Mohlke</surname><given-names>KL</given-names></name><name><surname>Morken</surname><given-names>MA</given-names></name><name><surname>Narisu</surname><given-names>N</given-names></name><name><surname>Palmer</surname><given-names>CN</given-names></name><name><surname>Pakyz</surname><given-names>R</given-names></name><name><surname>Pascoe</surname><given-names>L</given-names></name><name><surname>Payne</surname><given-names>F</given-names></name><name><surname>Pearson</surname><given-names>D</given-names></name><name><surname>Rathmann</surname><given-names>W</given-names></name><name><surname>Sandbaek</surname><given-names>A</given-names></name><name><surname>Sayer</surname><given-names>AA</given-names></name><name><surname>Scott</surname><given-names>LJ</given-names></name><name><surname>Sharp</surname><given-names>SJ</given-names></name><name><surname>Sijbrands</surname><given-names>E</given-names></name><name><surname>Singleton</surname><given-names>A</given-names></name><name><surname>Siscovick</surname><given-names>DS</given-names></name><name><surname>Smith</surname><given-names>NL</given-names></name><name><surname>Sparso</surname><given-names>T</given-names></name><etal/></person-group><article-title>Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge</article-title><source>Nat Genet</source><year>2010</year><volume>42</volume><fpage>142</fpage><lpage>148</lpage><pub-id pub-id-type="doi">10.1038/ng.521</pub-id><pub-id pub-id-type="pmid">20081857</pub-id></mixed-citation></ref><ref id="CR26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scott</surname><given-names>LJ</given-names></name><name><surname>Mohlke</surname><given-names>KL</given-names></name><name><surname>Bonnycastle</surname><given-names>LL</given-names></name><name><surname>Willer</surname><given-names>CJ</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Duren</surname><given-names>WL</given-names></name><name><surname>Erdos</surname><given-names>MR</given-names></name><name><surname>Stringham</surname><given-names>HM</given-names></name><name><surname>Chines</surname><given-names>PS</given-names></name><name><surname>Jackson</surname><given-names>AU</given-names></name><name><surname>Prokunina-Olsson</surname><given-names>L</given-names></name><name><surname>Ding</surname><given-names>CJ</given-names></name><name><surname>Swift</surname><given-names>AJ</given-names></name><name><surname>Narisu</surname><given-names>N</given-names></name><name><surname>Hu</surname><given-names>T</given-names></name><name><surname>Pruim</surname><given-names>R</given-names></name><name><surname>Xiao</surname><given-names>R</given-names></name><name><surname>Li</surname><given-names>XY</given-names></name><name><surname>Conneely</surname><given-names>KN</given-names></name><name><surname>Riebow</surname><given-names>NL</given-names></name><name><surname>Sprau</surname><given-names>AG</given-names></name><name><surname>Tong</surname><given-names>M</given-names></name><name><surname>White</surname><given-names>PP</given-names></name><name><surname>Hetrick</surname><given-names>KN</given-names></name><name><surname>Barnhart</surname><given-names>MW</given-names></name><name><surname>Bark</surname><given-names>CW</given-names></name><name><surname>Goldstein</surname><given-names>JL</given-names></name><name><surname>Watkins</surname><given-names>L</given-names></name><name><surname>Xiang</surname><given-names>F</given-names></name><name><surname>Saramies</surname><given-names>J</given-names></name><name><surname>Buchanan</surname><given-names>TA</given-names></name><name><surname>Watanabe</surname><given-names>RM</given-names></name><name><surname>Valle</surname><given-names>TT</given-names></name><name><surname>Kinnunen</surname><given-names>L</given-names></name><name><surname>Abecasis</surname><given-names>GR</given-names></name><name><surname>Pugh</surname><given-names>EW</given-names></name><name><surname>Doheny</surname><given-names>KF</given-names></name><name><surname>Bergman</surname><given-names>RN</given-names></name><name><surname>Tuomilehto</surname><given-names>J</given-names></name><name><surname>Collins</surname><given-names>FS</given-names></name><name><surname>Boehnke</surname><given-names>M</given-names></name></person-group><article-title>A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants</article-title><source>Science</source><year>2007</year><volume>316</volume><fpage>1341</fpage><lpage>1345</lpage><pub-id pub-id-type="doi">10.1126/science.1142382</pub-id><pub-id pub-id-type="pmid">17463248</pub-id></mixed-citation></ref><ref id="CR27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Slentz</surname><given-names>CA</given-names></name><name><surname>Houmard</surname><given-names>JA</given-names></name><name><surname>Johnson</surname><given-names>JL</given-names></name><name><surname>Bateman</surname><given-names>LA</given-names></name><name><surname>Tanner</surname><given-names>CJ</given-names></name><name><surname>McCartney</surname><given-names>JS</given-names></name><name><surname>Duscha</surname><given-names>BD</given-names></name><name><surname>Kraus</surname><given-names>WE</given-names></name></person-group><article-title>Inactivity, exercise training and detraining, and plasma lipoproteins. STRRIDE: a randomized, controlled study of exercise intensity and amount</article-title><source>J Appl Physiol</source><year>2007</year><volume>103</volume><fpage>432</fpage><lpage>442</lpage><pub-id pub-id-type="doi">10.1152/japplphysiol.01314.2006</pub-id><pub-id pub-id-type="pmid">17395756</pub-id></mixed-citation></ref><ref id="CR28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stephens</surname><given-names>M</given-names></name><name><surname>Smith</surname><given-names>NJ</given-names></name><name><surname>Donnelly</surname><given-names>P</given-names></name></person-group><article-title>A new statistical method for haplotype reconstruction from population data</article-title><source>Am J Hum Genet</source><year>2001</year><volume>68</volume><fpage>978</fpage><lpage>989</lpage><pub-id pub-id-type="doi">10.1086/319501</pub-id><pub-id pub-id-type="pmid">11254454</pub-id></mixed-citation></ref><ref id="CR29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stern</surname><given-names>MP</given-names></name></person-group><article-title>Invited commentary: cardiovascular mortality in American Indians: paradox explained?</article-title><source>Am J Epidemiol</source><year>1998</year><volume>147</volume><fpage>1009</fpage><lpage>1010</lpage><pub-id pub-id-type="pmid">9620043</pub-id></mixed-citation></ref><ref id="CR30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>XJ</given-names></name><name><surname>Rothenberg</surname><given-names>P</given-names></name><name><surname>Kahn</surname><given-names>CR</given-names></name><name><surname>Backer</surname><given-names>JM</given-names></name><name><surname>Araki</surname><given-names>E</given-names></name><name><surname>Wilden</surname><given-names>PA</given-names></name><name><surname>Cahill</surname><given-names>DA</given-names></name><name><surname>Goldstein</surname><given-names>BJ</given-names></name><name><surname>White</surname><given-names>MF</given-names></name></person-group><article-title>Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein</article-title><source>Nature</source><year>1991</year><volume>352</volume><fpage>73</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1038/352073a0</pub-id><pub-id pub-id-type="pmid">1648180</pub-id></mixed-citation></ref><ref id="CR31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>XJ</given-names></name><name><surname>Wang</surname><given-names>LM</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Yenush</surname><given-names>L</given-names></name><name><surname>Myers</surname><given-names>MG</given-names><suffix>Jr</suffix></name><name><surname>Glasheen</surname><given-names>E</given-names></name><name><surname>Lane</surname><given-names>WS</given-names></name><name><surname>Pierce</surname><given-names>JH</given-names></name><name><surname>White</surname><given-names>MF</given-names></name></person-group><article-title>Role of IRS-2 in insulin and cytokine signalling</article-title><source>Nature</source><year>1995</year><volume>377</volume><fpage>173</fpage><lpage>177</lpage><pub-id pub-id-type="doi">10.1038/377173a0</pub-id><pub-id pub-id-type="pmid">7675087</pub-id></mixed-citation></ref><ref id="CR32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teslovich</surname><given-names>TM</given-names></name><name><surname>Musunuru</surname><given-names>K</given-names></name><name><surname>Smith</surname><given-names>AV</given-names></name><name><surname>Edmondson</surname><given-names>AC</given-names></name><name><surname>Stylianou</surname><given-names>IM</given-names></name><name><surname>Koseki</surname><given-names>M</given-names></name><name><surname>Pirruccello</surname><given-names>JP</given-names></name><name><surname>Ripatti</surname><given-names>S</given-names></name><name><surname>Chasman</surname><given-names>DI</given-names></name><name><surname>Willer</surname><given-names>CJ</given-names></name><name><surname>Johansen</surname><given-names>CT</given-names></name><name><surname>Fouchier</surname><given-names>SW</given-names></name><name><surname>Isaacs</surname><given-names>A</given-names></name><name><surname>Peloso</surname><given-names>GM</given-names></name><name><surname>Barbalic</surname><given-names>M</given-names></name><name><surname>Ricketts</surname><given-names>SL</given-names></name><name><surname>Bis</surname><given-names>JC</given-names></name><name><surname>Aulchenko</surname><given-names>YS</given-names></name><name><surname>Thorleifsson</surname><given-names>G</given-names></name><name><surname>Feitosa</surname><given-names>MF</given-names></name><name><surname>Chambers</surname><given-names>J</given-names></name><name><surname>Orho-Melander</surname><given-names>M</given-names></name><name><surname>Melander</surname><given-names>O</given-names></name><name><surname>Johnson</surname><given-names>T</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Guo</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Shin Cho</surname><given-names>Y</given-names></name><name><surname>Jin Go</surname><given-names>M</given-names></name><name><surname>Jin Kim</surname><given-names>Y</given-names></name><name><surname>Lee</surname><given-names>JY</given-names></name><name><surname>Park</surname><given-names>T</given-names></name><name><surname>Kim</surname><given-names>K</given-names></name><name><surname>Sim</surname><given-names>X</given-names></name><name><surname>Twee-Hee Ong</surname><given-names>R</given-names></name><name><surname>Croteau-Chonka</surname><given-names>DC</given-names></name><name><surname>Lange</surname><given-names>LA</given-names></name><name><surname>Smith</surname><given-names>JD</given-names></name><name><surname>Song</surname><given-names>K</given-names></name><name><surname>Hua Zhao</surname><given-names>J</given-names></name><name><surname>Yuan</surname><given-names>X</given-names></name><name><surname>Luan</surname><given-names>J</given-names></name><name><surname>Lamina</surname><given-names>C</given-names></name><name><surname>Ziegler</surname><given-names>A</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Zee</surname><given-names>RY</given-names></name><name><surname>Wright</surname><given-names>AF</given-names></name><name><surname>Witteman</surname><given-names>JC</given-names></name><name><surname>Wilson</surname><given-names>JF</given-names></name><name><surname>Willemsen</surname><given-names>G</given-names></name><name><surname>Wichmann</surname><given-names>HE</given-names></name><name><surname>Whitfield</surname><given-names>JB</given-names></name><name><surname>Waterworth</surname><given-names>DM</given-names></name><name><surname>Wareham</surname><given-names>NJ</given-names></name><name><surname>Waeber</surname><given-names>G</given-names></name><name><surname>Vollenweider</surname><given-names>P</given-names></name><name><surname>Voight</surname><given-names>BF</given-names></name><name><surname>Vitart</surname><given-names>V</given-names></name><name><surname>Uitterlinden</surname><given-names>AG</given-names></name><name><surname>Uda</surname><given-names>M</given-names></name><name><surname>Tuomilehto</surname><given-names>J</given-names></name><name><surname>Thompson</surname><given-names>JR</given-names></name><name><surname>Tanaka</surname><given-names>T</given-names></name><name><surname>Surakka</surname><given-names>I</given-names></name><name><surname>Stringham</surname><given-names>HM</given-names></name><name><surname>Spector</surname><given-names>TD</given-names></name><name><surname>Soranzo</surname><given-names>N</given-names></name><name><surname>Smit</surname><given-names>JH</given-names></name><name><surname>Sinisalo</surname><given-names>J</given-names></name><name><surname>Silander</surname><given-names>K</given-names></name><name><surname>Sijbrands</surname><given-names>EJ</given-names></name><name><surname>Scuteri</surname><given-names>A</given-names></name><name><surname>Scott</surname><given-names>J</given-names></name><name><surname>Schlessinger</surname><given-names>D</given-names></name><name><surname>Sanna</surname><given-names>S</given-names></name><name><surname>Salomaa</surname><given-names>V</given-names></name><name><surname>Saharinen</surname><given-names>J</given-names></name><name><surname>Sabatti</surname><given-names>C</given-names></name><name><surname>Ruokonen</surname><given-names>A</given-names></name><name><surname>Rudan</surname><given-names>I</given-names></name><name><surname>Rose</surname><given-names>LM</given-names></name><name><surname>Roberts</surname><given-names>R</given-names></name><name><surname>Rieder</surname><given-names>M</given-names></name><name><surname>Psaty</surname><given-names>BM</given-names></name><name><surname>Pramstaller</surname><given-names>PP</given-names></name><name><surname>Pichler</surname><given-names>I</given-names></name><name><surname>Perola</surname><given-names>M</given-names></name><name><surname>Penninx</surname><given-names>BW</given-names></name><name><surname>Pedersen</surname><given-names>NL</given-names></name><name><surname>Pattaro</surname><given-names>C</given-names></name><name><surname>Parker</surname><given-names>AN</given-names></name><name><surname>Pare</surname><given-names>G</given-names></name><name><surname>Oostra</surname><given-names>BA</given-names></name><name><surname>O&#x02019;Donnell</surname><given-names>CJ</given-names></name><name><surname>Nieminen</surname><given-names>MS</given-names></name><name><surname>Nickerson</surname><given-names>DA</given-names></name><name><surname>Montgomery</surname><given-names>GW</given-names></name><name><surname>Meitinger</surname><given-names>T</given-names></name><name><surname>McPherson</surname><given-names>R</given-names></name><name><surname>McCarthy</surname><given-names>MI</given-names></name><etal/></person-group><article-title>Biological, clinical and population relevance of 95 loci for blood lipids</article-title><source>Nature</source><year>2010</year><volume>466</volume><fpage>707</fpage><lpage>713</lpage><pub-id pub-id-type="doi">10.1038/nature09270</pub-id><pub-id pub-id-type="pmid">20686565</pub-id></mixed-citation></ref><ref id="CR33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thompson</surname><given-names>PD</given-names></name><name><surname>Moyna</surname><given-names>N</given-names></name><name><surname>Seip</surname><given-names>R</given-names></name><name><surname>Price</surname><given-names>T</given-names></name><name><surname>Clarkson</surname><given-names>P</given-names></name><name><surname>Angelopoulos</surname><given-names>T</given-names></name><name><surname>Gordon</surname><given-names>P</given-names></name><name><surname>Pescatello</surname><given-names>L</given-names></name><name><surname>Visich</surname><given-names>P</given-names></name><name><surname>Zoeller</surname><given-names>R</given-names></name><name><surname>Devaney</surname><given-names>JM</given-names></name><name><surname>Gordish</surname><given-names>H</given-names></name><name><surname>Bilbie</surname><given-names>S</given-names></name><name><surname>Hoffman</surname><given-names>EP</given-names></name></person-group><article-title>Functional polymorphisms associated with human muscle size and strength</article-title><source>Med Sci Sports Exerc</source><year>2004</year><volume>36</volume><fpage>1132</fpage><lpage>1139</lpage><pub-id pub-id-type="doi">10.1249/01.MSS.0000132274.26612.23</pub-id><pub-id pub-id-type="pmid">15235316</pub-id></mixed-citation></ref><ref id="CR34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tuttle</surname><given-names>RL</given-names></name><name><surname>Gill</surname><given-names>NS</given-names></name><name><surname>Pugh</surname><given-names>W</given-names></name><name><surname>Lee</surname><given-names>JP</given-names></name><name><surname>Koeberlein</surname><given-names>B</given-names></name><name><surname>Furth</surname><given-names>EE</given-names></name><name><surname>Polonsky</surname><given-names>KS</given-names></name><name><surname>Naji</surname><given-names>A</given-names></name><name><surname>Birnbaum</surname><given-names>MJ</given-names></name></person-group><article-title>Regulation of pancreatic beta-cell growth and survival by the serine/threonine protein kinase Akt1/PKBalpha</article-title><source>Nat Med</source><year>2001</year><volume>7</volume><fpage>1133</fpage><lpage>1137</lpage><pub-id pub-id-type="doi">10.1038/nm1001-1133</pub-id><pub-id pub-id-type="pmid">11590437</pub-id></mixed-citation></ref><ref id="CR35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uthurralt</surname><given-names>J</given-names></name><name><surname>Gordish-Dressman</surname><given-names>H</given-names></name><name><surname>Bradbury</surname><given-names>M</given-names></name><name><surname>Tesi-Rocha</surname><given-names>C</given-names></name><name><surname>Devaney</surname><given-names>J</given-names></name><name><surname>Harmon</surname><given-names>B</given-names></name><name><surname>Reeves</surname><given-names>EK</given-names></name><name><surname>Brandoli</surname><given-names>C</given-names></name><name><surname>Hansen</surname><given-names>BC</given-names></name><name><surname>Seip</surname><given-names>RL</given-names></name><name><surname>Thompson</surname><given-names>PD</given-names></name><name><surname>Price</surname><given-names>TB</given-names></name><name><surname>Angelopoulos</surname><given-names>TJ</given-names></name><name><surname>Clarkson</surname><given-names>PM</given-names></name><name><surname>Moyna</surname><given-names>NM</given-names></name><name><surname>Pescatello</surname><given-names>LS</given-names></name><name><surname>Visich</surname><given-names>PS</given-names></name><name><surname>Zoeller</surname><given-names>RF</given-names></name><name><surname>Gordon</surname><given-names>PM</given-names></name><name><surname>Hoffman</surname><given-names>EP</given-names></name></person-group><article-title>PPARalpha L162V underlies variation in serum triglycerides and subcutaneous fat volume in young males</article-title><source>BMC Med Genet</source><year>2007</year><volume>8</volume><fpage>55</fpage><pub-id pub-id-type="doi">10.1186/1471-2350-8-55</pub-id><pub-id pub-id-type="pmid">17705849</pub-id></mixed-citation></ref><ref id="CR36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Visser</surname><given-names>M</given-names></name><name><surname>Fuerst</surname><given-names>T</given-names></name><name><surname>Lang</surname><given-names>T</given-names></name><name><surname>Salamone</surname><given-names>L</given-names></name><name><surname>Harris</surname><given-names>TB</given-names></name></person-group><article-title>Validity of fan-beam dual-energy X-ray absorptiometry for measuring fat-free mass and leg muscle mass. Health, Aging, and Body Composition Study&#x02013;Dual-Energy X-ray Absorptiometry and Body Composition Working Group</article-title><source>J Appl Physiol</source><year>1999</year><volume>87</volume><fpage>1513</fpage><lpage>1520</lpage><pub-id pub-id-type="pmid">10517786</pub-id></mixed-citation></ref><ref id="CR1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><collab>Wellcome Trust Case Control Consortium</collab></person-group><article-title>Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls</article-title><source>Nature</source><year>2007</year><volume>447</volume><fpage>661</fpage><lpage>678</lpage><pub-id pub-id-type="doi">10.1038/nature05911</pub-id><pub-id pub-id-type="pmid">17554300</pub-id></mixed-citation></ref><ref id="CR38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zdychova</surname><given-names>J</given-names></name><name><surname>Komers</surname><given-names>R</given-names></name></person-group><article-title>Emerging role of Akt kinase/protein kinase B signaling in pathophysiology of diabetes and its complications</article-title><source>Physiol Res</source><year>2005</year><volume>54</volume><fpage>1</fpage><lpage>16</lpage><pub-id pub-id-type="pmid">15717836</pub-id></mixed-citation></ref><ref id="CR39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeggini</surname><given-names>E</given-names></name><name><surname>Scott</surname><given-names>LJ</given-names></name><name><surname>Saxena</surname><given-names>R</given-names></name><name><surname>Voight</surname><given-names>BF</given-names></name><name><surname>Marchini</surname><given-names>JL</given-names></name><name><surname>Hu</surname><given-names>T</given-names></name><name><surname>Bakker</surname><given-names>PI</given-names></name><name><surname>Abecasis</surname><given-names>GR</given-names></name><name><surname>Almgren</surname><given-names>P</given-names></name><name><surname>Andersen</surname><given-names>G</given-names></name><name><surname>Ardlie</surname><given-names>K</given-names></name><name><surname>Bostrom</surname><given-names>KB</given-names></name><name><surname>Bergman</surname><given-names>RN</given-names></name><name><surname>Bonnycastle</surname><given-names>LL</given-names></name><name><surname>Borch-Johnsen</surname><given-names>K</given-names></name><name><surname>Burtt</surname><given-names>NP</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Chines</surname><given-names>PS</given-names></name><name><surname>Daly</surname><given-names>MJ</given-names></name><name><surname>Deodhar</surname><given-names>P</given-names></name><name><surname>Ding</surname><given-names>CJ</given-names></name><name><surname>Doney</surname><given-names>AS</given-names></name><name><surname>Duren</surname><given-names>WL</given-names></name><name><surname>Elliott</surname><given-names>KS</given-names></name><name><surname>Erdos</surname><given-names>MR</given-names></name><name><surname>Frayling</surname><given-names>TM</given-names></name><name><surname>Freathy</surname><given-names>RM</given-names></name><name><surname>Gianniny</surname><given-names>L</given-names></name><name><surname>Grallert</surname><given-names>H</given-names></name><name><surname>Grarup</surname><given-names>N</given-names></name><name><surname>Groves</surname><given-names>CJ</given-names></name><name><surname>Guiducci</surname><given-names>C</given-names></name><name><surname>Hansen</surname><given-names>T</given-names></name><name><surname>Herder</surname><given-names>C</given-names></name><name><surname>Hitman</surname><given-names>GA</given-names></name><name><surname>Hughes</surname><given-names>TE</given-names></name><name><surname>Isomaa</surname><given-names>B</given-names></name><name><surname>Jackson</surname><given-names>AU</given-names></name><name><surname>Jorgensen</surname><given-names>T</given-names></name><name><surname>Kong</surname><given-names>A</given-names></name><name><surname>Kubalanza</surname><given-names>K</given-names></name><name><surname>Kuruvilla</surname><given-names>FG</given-names></name><name><surname>Kuusisto</surname><given-names>J</given-names></name><name><surname>Langenberg</surname><given-names>C</given-names></name><name><surname>Lango</surname><given-names>H</given-names></name><name><surname>Lauritzen</surname><given-names>T</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Lindgren</surname><given-names>CM</given-names></name><name><surname>Lyssenko</surname><given-names>V</given-names></name><name><surname>Marvelle</surname><given-names>AF</given-names></name><name><surname>Meisinger</surname><given-names>C</given-names></name><name><surname>Midthjell</surname><given-names>K</given-names></name><name><surname>Mohlke</surname><given-names>KL</given-names></name><name><surname>Morken</surname><given-names>MA</given-names></name><name><surname>Morris</surname><given-names>AD</given-names></name><name><surname>Narisu</surname><given-names>N</given-names></name><name><surname>Nilsson</surname><given-names>P</given-names></name><name><surname>Owen</surname><given-names>KR</given-names></name><name><surname>Palmer</surname><given-names>CN</given-names></name><name><surname>Payne</surname><given-names>F</given-names></name><name><surname>Perry</surname><given-names>JR</given-names></name><name><surname>Pettersen</surname><given-names>E</given-names></name><name><surname>Platou</surname><given-names>C</given-names></name><name><surname>Prokopenko</surname><given-names>I</given-names></name><name><surname>Qi</surname><given-names>L</given-names></name><name><surname>Qin</surname><given-names>L</given-names></name><name><surname>Rayner</surname><given-names>NW</given-names></name><name><surname>Rees</surname><given-names>M</given-names></name><name><surname>Roix</surname><given-names>JJ</given-names></name><name><surname>Sandbaek</surname><given-names>A</given-names></name><name><surname>Shields</surname><given-names>B</given-names></name><name><surname>Sjogren</surname><given-names>M</given-names></name><name><surname>Steinthorsdottir</surname><given-names>V</given-names></name><name><surname>Stringham</surname><given-names>HM</given-names></name><name><surname>Swift</surname><given-names>AJ</given-names></name><name><surname>Thorleifsson</surname><given-names>G</given-names></name><name><surname>Thorsteinsdottir</surname><given-names>U</given-names></name><name><surname>Timpson</surname><given-names>NJ</given-names></name><name><surname>Tuomi</surname><given-names>T</given-names></name><name><surname>Tuomilehto</surname><given-names>J</given-names></name><name><surname>Walker</surname><given-names>M</given-names></name><name><surname>Watanabe</surname><given-names>RM</given-names></name><name><surname>Weedon</surname><given-names>MN</given-names></name><name><surname>Willer</surname><given-names>CJ</given-names></name><name><surname>Illig</surname><given-names>T</given-names></name><name><surname>Hveem</surname><given-names>K</given-names></name><name><surname>Hu</surname><given-names>FB</given-names></name><name><surname>Laakso</surname><given-names>M</given-names></name><name><surname>Stefansson</surname><given-names>K</given-names></name><name><surname>Pedersen</surname><given-names>O</given-names></name><name><surname>Wareham</surname><given-names>NJ</given-names></name><name><surname>Barroso</surname><given-names>I</given-names></name><name><surname>Hattersley</surname><given-names>AT</given-names></name><name><surname>Collins</surname><given-names>FS</given-names></name><name><surname>Groop</surname><given-names>L</given-names></name><name><surname>McCarthy</surname><given-names>MI</given-names></name><name><surname>Boehnke</surname><given-names>M</given-names></name><name><surname>Altshuler</surname><given-names>D</given-names></name></person-group><article-title>Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes</article-title><source>Nat Genet</source><year>2008</year><volume>40</volume><fpage>638</fpage><lpage>645</lpage><pub-id pub-id-type="doi">10.1038/ng.120</pub-id><pub-id pub-id-type="pmid">18372903</pub-id></mixed-citation></ref><ref id="CR40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zoeller</surname><given-names>RF</given-names></name><name><surname>Ryan</surname><given-names>ED</given-names></name><name><surname>Gordish-Dressman</surname><given-names>H</given-names></name><name><surname>Price</surname><given-names>TB</given-names></name><name><surname>Seip</surname><given-names>RL</given-names></name><name><surname>Angelopoulos</surname><given-names>TJ</given-names></name><name><surname>Moyna</surname><given-names>NM</given-names></name><name><surname>Gordon</surname><given-names>PM</given-names></name><name><surname>Thompson</surname><given-names>PD</given-names></name><name><surname>Hoffman</surname><given-names>EP</given-names></name></person-group><article-title>Allometric scaling of biceps strength before and after resistance training in men</article-title><source>Med Sci Sports Exerc</source><year>2007</year><volume>39</volume><fpage>1013</fpage><lpage>1019</lpage><pub-id pub-id-type="doi">10.1249/mss.0b013e3180423aad</pub-id><pub-id pub-id-type="pmid">17545893</pub-id></mixed-citation></ref></ref-list></back></article>